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ABSTRACT 
Oral vs Nasal Breathing During Submaximal Aerobic Exercise  
By Chase LaComb 
James Navalta, Examination Committee Chair 
Assistant Professor of Kinesiology 
University of Nevada, Las Vegas 
 
When comparing oral breathing versus nasal breathing more volume of air can be 
transported through the oral passageway, but nasal breathing can lead to slower 
respiration rates and cleaner inspired air.  The purpose of this study is to find the most 
efficient mode of breathing during different intensities of submaximal aerobic exercise.  
There were 9 males and 10 females that completed this study.  First test was a VO2 Max 
test, 3.0 mph for 3 minutes, with increases in 1.0 mph every minute after that.  Using a 
regression equation running speeds were determined for each individual’s submaximal 
intensities.  The desire was to have each individual complete 4 minutes on the treadmill at 
50%, 65%, and 80% of VO2 max.  One trial was completed by nasally and other orally.   
Oral breathing was significantly greater (p<.05) in all three intensities (50%, 65%, and 
80%) in RR, VE, VO2/kg, VO2, and VCO2.  Oral breathing creates greater respiratory 
rates and allows for greater volumes of air to be transferred to the lungs; combined with 
greater O2 consumption and CO2 expiration this breathing mode met the exercise 
demands more proficiently.  With greater respiratory and metabolic demands met in oral 
breathing it provided the more suitable breathing mode for intensities greater than 50% 
VO2 max.  Steady state did not seem to be reached in nasal breathing during the short 4 
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minute stages.  There were beliefs that anaerobic contributions during the nasal breathing 
mode allowed for measures to create similar responses.   
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Chapter 1 
Introduction 
Respiration is a fundamental physiological process that warrants exploration in 
finding the most efficient breathing mode during exercise.  There are multiple modes in 
which an individual can breathe: through the mouth, nose, a tracheostomy tube, or 
combinations of these modes.  In healthy individuals, breathing will occur predominantly 
through the nasal cavity at rest and combination of oronasal breathing during exercise.  
At rest, over 90% of inspiration occurs nasally (Camner and Bakke, 1980).   Oral 
breathing will exchange greater volumes of air at maximal intensities.  During varying 
intensities of exercise there are advantages and benefits for different modes of breathing.  
Finding the most effective breathing mode at submaximal intensities is the desire for the 
proposed study.        
At rest nasal breathing dominates respiration and at maximal intensities of 
exercise oral breathing is required; however, it is unknown which specific breathing 
modes are preferred at differing submaximal intensities.  Although moderate submaximal 
exercise would not dictate one breathing mode completely, it is possible that one mode 
could work more efficiently than the other.  Determining the favorable intensity of each 
breathing mode could yield further information to an increase in aerobic performance in 
individuals.  There is a gap in the research investigating submaximal intensities.  
Research has been conducted at rest and at maximal values, but limited studies have been 
conducted examining moderate workloads.  One such study by Hall et al. (2006) found at 
60% of maximal oxygen consumption (VO2 max) that oral breathing produced 
significantly higher oxygen consumption (VO2), ventilation (VE), and respiration rate 
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(RR) than nasal breathing.  With VO2 being higher in oral breathing is that primarily 
from different volumes of air being transported to lungs or is there a work capacity 
difference between the two breathing modes?  RR and VE should create lower values in 
nasal breathing, but VO2 is the variable that should warrant greater examination.  
Determining the intensity nasal breathing begins to inhibit athletic performance and 
moment to incorporate oral breathing is the underlying mechanism to investigate.   
This investigation is a replication of an unpublished study by LaComb et al. 
(2014).  Nasal vs oral breathing was examined during treadmill running in 18 healthy 
college students.  Moderate intensities of 50, 65, and 80% of each individuals VO2 max 
were the work rates completed at 5 minute stages.  There was a significant higher 
response (p<.05) in oral breathing in RR, ventilatory equivalent for oxygen content 
(Veq/O2), ventilatory equivalent for carbon dioxide content (Veq/CO2), end tidal 
concentration of O2 (ETO2), and end tidal concentration of CO2 (ETCO2) at all 
workloads.  Absolute VO2 (L/min) was significantly higher at 80% for nasal breathing 
(p<.05).  RR represented nasal breathing having slower, deeper breaths to maintain the 
same work rates.  Oral breathing occurred in shallow, quick breaths; probably due to the 
need to receive more O2 into the lungs and higher CO2 values in the body.  CO2 is the 
driving force for respiration and the study provided evidence that oral breathing had 
greater Veq/CO2 and ETCO2.  It is likely that more prevalent CO2 concentrations led to a 
higher perception to require more breathing, enticing the higher respiration rates.  The 
Veq/O2 levels were significantly lower in nasal breathing, providing evidence that in 
nasal breathing per volume of air there was less O2 content in the air than oral breathing.  
Less O2 content will result in a decrease in exercise performance.  The last stage there 
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was a greater VO2 in nasal breathing. With nasal breathing producing greater VO2 at the 
last intensity it could be postulated that O2 was utilized better or demands were much 
higher causing a greater work output to maintain the intensity.   All intensities produced 
lower Veq/O2 values in nasal breathing, creating the assumption that nasal breathing 
required more work to be completed by the body.  Greater O2 demand was necessary to 
produce the ability to work at the desired 80% max intensity.   
Therefore, oral breathing seems to be more efficient at the 80% intensity, but have 
mixed conclusions with regards to the other intensities and further investigation is 
warranted.   The study previously mentioned needs to be reexamined, due to the 
equipment used during investigation.  There have been previous studies measuring the 
switching point between nasal and oronasal (combined nose and mouth) breathing.  No 
airways were restricted and allowed for normal transfer from nasal to nasal and oral to 
occur.  The effects of breathing nasally are comfortable at lower intensities, but generally 
at 35-41 L/min total ventilation (VE) individuals switch from breathing nasally to 
oronasal breathing (Ninnima et al. 1980, Campbell 1984).  Multiple studies have tried to 
find the exact switching point but deviations in study results show that there is no set 
point due to wide variance in individuals’ breathing patterns.  The size of the nasal 
airway was the greatest contributor to the switching point as found by Ninnima (1980).  
The larger the nostrils and size of the nasal cavity the longer the individual was able to 
breathe through the nose.  An individual with a nasal airway less than .4 cm2 was known 
to have airway impairment and unable to sustain nasal breathing beyond the desired work 
capacity, which occurred in roughly 12% of the subjects (Warren 1988).    
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Nasal breathing has also been shown to be beneficial during the post exercise 
period.  Mangla and Menon (1980) observed asthmatics and non-asthmatics during oral 
vs nasal breathing.  They found a significant lower (p<.05) with post exercise forced 
expiratory volume (FEV1) rates in nasal breathing compared to oral breathing in both 
groups.  When the participants were directed to breath only through their nose there was a 
markedly different post-exercise bronchoconstrictive response.  It was suggested that 
nasal breathing could reduce exercise-induced asthma or bronchoconstriction in all 
individuals.  Breathing nasally increases flow rates of air throughout the lungs.   
Nasal versus oral breathing can lead to different physiological responses in the 
body.  Oral breathing will produce a greater volume of air to be utilized by the human 
body.  Nasal breathing can clean the air, produce Nitric Oxide, and produce the same 
amount of work at easier work rates.  The proposed study will compare the physiological 
effects of nasal versus mouth breathing at multiple work rates between 50% - 80% of 
VO2 max, to see which mode of breathing is more efficient and most suitable in a diverse 
population with varying habitual daily activity levels.  The findings of this study may 
lead to further awareness if varying intensities are completed more efficiently with 
specific breathing modes. Acclimatizing to nasal breathing, could further advance 
individuals in their abilities to breathe more efficiently and produce improved 
performances compared to mouth breathing.    
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Purpose 
 The purpose of the study is to find the most efficient breathing mode at different 
submaximal intensities.  Secondly, the specific work intensity of which breathing mode is 
more efficient for oxygen consumption.   
 
Research Question 
 Research Hypothesis:  Nasal breathing will have lower respiratory values while 
maintaining metabolic rates between 50% and 65% of an individual’s VO2 max during 
aerobic exercise, but oral breathing will provide greater metabolic responses at the 80% 
VO2 max.  
Limitations 
 The ability to test forced expiratory volumes (FEV1) at the end of each stage is a 
limitation in this study.  There would be a benefit to examine the effect of maximal 
exhalations at the completion of each stage.  During pilot tests, there were 30-40 second 
delays before completing the exhaled maneuvers.  Specifically, the mask has three knobs 
that would have to be unscrewed, two tubes taken out, and the respiration mask to have 
two latches disassembled before giving the subject the spirometer.  For best results the 
spirometer test should occur <10 seconds of cessation of exercise.   
 Another limitation is finding nasal breathers that have adapted or acclimatized to 
nasal breathing.  Through recruitment, it may be difficult to not be biased and state nasal 
breathing adaptation or practice is desired, but findings subjects with experience in nasal 
breathing will likely be difficult.    Did not want to measure adaptation of nasal breathing, 
but that would be an effect and create a limitation on the study.  Last limitation would be 
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the ability to measure nasal resistance.  On site we do not have anything to obtain 
accurate nasal passageway measurements.   
 
Significance 
The significance of this study is to examine the physiological responses of 
individuals at 50%, 65%, and 80% while breathing through the nose only and the mouth 
only.  Benefits of this study has the potential to help endurance athletes in maximizing 
work capacity, help individuals with respiratory problems, sleep apnea, 
bronchoconstriction, and general population in living a healthier life.  Familiarization to 
nasal breathing could further advance individuals in their abilities to breathe more 
efficiently and improve performances compared to breathing orally.    
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Chapter 2 
REVIEW OF RELATED LITERATURE 
Empirical Literature Review 
Primary function of the nose is to smell; role of mouth is to chew and digest food.  
Each serve primary functions for survival, but the main focus in the present study is their 
role in breathing.  Breathing or ventilation is gas exchange from the outside environment 
to the alveoli.  The nose has numerous functions: olfaction, sensation, immunology, 
mucociliary clearance, filtration, warm and humidify, and nasal cycle with airflow 
dynamics (Jones et al., 2001).   
Olfaction is the sense of smell, or the ability of the nose to sense odor in the nasal 
cavity.  Humans can detect more than 10,000 odors.  Smell is recognized by chemical 
receptors sensing the air passing through the nasal cavity.  Epithelial tissue in the nose 
picks up the smell and transmits signals through the olfactory nerve to the brain.   Most 
smells are then deciphered into the different sensations of smell we possess.  There can 
be an irritation or burning sensation which occurs from branches of the trigeminal nerve 
and glossopharyngeal nerve that send information to the spinal trigeminal nucleus, 
thalamus and somatosensory cortex.  
Immunology functions of the nose produce mucus and secrete immunoglobulins.  
The nose has its own self-defense because of the coarse hairs (vibrissae) and secretions it 
creates.  The nose protects the lungs from allergens, toxicants, and other bacteria with its 
immunology properties.  Mucociliary clearance promotes mucus and cilia functions: to 
filter, trap toxicants and transporting airborne particles.   Particles greater than 30µm are 
removed as they are too large and inhibit respiration rate, along with the majority of 
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particles as small as 12µm which are also filtered (Jones et al., 2001).  Humidification 
occurs within 80% of the air before it reaches the lungs.  Air is heated through 
conduction, convection and radiation with blood flow in the opposite direction to 
incoming airflow, in response allows for greater efficiency of warming the air (Swift, 
1982).  Overall this process can warm the air up to 3°C in the nasal cavity.   
The nasal airway represents 2/3 of the total airway resistance to the lungs!  Due to 
the elaborate properties of the nose to filter and humidify foreign particles, it also inhibits 
air traveling to the bronchioles.  During every 3-7 hours each nostril will congest and 
decongest.  It is unclear what causes this mechanism.  This specific response is the 
greatest limiting factor to nasal breathing.   Overall, the nasal cycle allows for inhalation 
and exhalation, air being transported in and out of the body, completing the entire 
ventilatory cycle.   
Mouth physiology includes a wider array of functions.  The largest contribution 
the mouth plays upon the human body is mechanical digestion of food.  Other key roles 
that take place within the mouth include: speech, chemical digestion, taste, drinking, 
facial expressions, social bonding (kissing), and respiration.  The mouth produces all 
noises, sounds, and speech, our fundamentals for communication.  Exterior parts of the 
mouth contribute to facial expression such as smiling and frowning.  Social interaction 
between the vast populations of the world is primarily due to the combination of talking 
and facial mannerisms.  Humans break down food by mechanical and chemical digestion.  
Through mastication, the process of chewing, our teeth break down substances that are 
easier for our body to digest.  Chemical digestion is an aid to chewing, where saliva 
dissolves and furthers the process in helping humans digest food.  Saliva is secreted by 
  
9
the salivary glands, which produces salivary amylase.  Salivary amylase is an enzyme 
that starts the digestion of starch into dextrin and maltose.     
During respiration the oral cavity has far less resistance than the nasal cavity.   At 
higher demands of exercise it is normal to have a higher VE in the oral cavity than 
nasally.  During congestion of an airway, there can be different responses of respiration 
functions.  In children with enlarged tonsils and adenoids, there was a decrease in the 
maximal inspiratory pressure and muscles function (Pires et al. 2005).  Congestion of the 
nasal airway produced weaker maximal inspiratory forces and lower muscle output 
making it far more difficult to breathe nasally.  If an individual has a stuffy nose, 
experiences congestion, or has extra resistance in the nasal passageway it will inhibit 
ventilation through the nose.  Milanesi et al. (2014) investigated adults who were solely 
mouth breathers as children.  Over years of chronic mouth breathing and adaptation to 
relying on the oral cavity for all breathing, there were significantly lower inspiratory and 
expiratory maximal pressure (p<.05) through the mouth when compared to nose.  These 
years of oral breathing, severely limited the adults when tested on forced inspiratory and 
expiratory capabilities.  From overuse or lack of using the nasal cavity, oral breathing 
was weaker than individuals that who were not chronic oral breathers.  Overall findings 
from this cross sectional study of individuals, over the 10 years of optional breathing, 
capabilities of producing the same amount of air flow in each passageway has altered.  
This represents the effect of chronic mouth breathing over time and decrease in 
performance with overused thoracic muscles.   
Respiration 
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 Air enters the body through the nose or mouth, then travels down to the pharynx, 
through the trachea and into the bronchioles.  Transported air into the bronchioles will 
enter the alveoli by diffusion.  Diffusion of the O2 molecules will exit the alveoli and 
enter the blood in response to the lower pressure gradient in the alveoli to the capillaries.  
O2 in the blood is transported mainly through hemoglobin.   Hemoglobin is and iron 
containing molecule that transports up to four O2 molecules in red blood cells.  During 
circulation of O2 through the body, the molecules will be extracted and utilized by the 
tissues.  The work capacity will determine the demands for O2 consumption.  Higher 
demands will utilize and extract more O2 from the blood than lower intensities.  O2 will 
be used to fuel the muscles by creating adenotriphosphate (ATP) during continuous 
exercise.  The O2 has served its primary purpose of supplying energy for the tissues, 
which turns CO2 to the focus for the other key part of respiration.   
CO2 combines with H2O in the blood to form carbaminohemoglobin (H2CO3) 
with the aid of the enzyme, carbonic anhydrase.  The H2CO3 yields bicarbonate (HCO3) 
and hydrogen ion (H+).  CO2 is transported as HCO3 primarily through the body.   Once 
O2 reaches the tissues, the pressure of O2 decreases, limiting the demand, and reversing 
the previous mentioned reaction.  Excess H+ (leftovers of Hb + O2, with O2 being utilized 
by tissues) will react with readily available CO2 in the form of HCO3 to create H2CO3.  
The H2CO3 will then yield H2O and CO2 which is then available for diffusion back to the 
alveoli.   
As O2 is utilized, CO2 levels will increase due to waste from the tissues.   Higher 
CO2 levels, stimulate chemoreceptors which signal for greater activation of respiration, 
causing an increase in RR.  When completing the cycle, CO2 will eventually be 
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transported out of the capillaries and back into the alveoli.  Resulting in CO2 being 
transported out of the body by expiration.   
During quiet breathing expiration is completed as a passive response.  Breathing 
does not occur in response to forced actions of the respiratory muscles, but rather 
stimulation of the chemical sensations of the body upregulating the process.  Inspiration 
occurs with forced contractions of the diaphragm and intercostal muscles.  The phrenic 
nerve causes activation of the diaphragm and downward movement of the abdomen.  Due 
to CO2 levels driving respiration rates, increasing passive breathing would help lower 
total work completed upon the body.  During higher intensities, CO2 levels are elevated, 
therefore increasing RR and higher demands made on the body.  This idea will be 
discussed later as lower CO2 rates are desirable to allow for the body to work easier and 
more efficiently.  Utilizing passive breathing as successfully as possible could help 
improve the body’s energetics.   
The O2 enters the lungs, diffuses into the blood to the muscles, then CO2 is 
diffused back to lungs then out of the pharynx.  For optimal aerobic performance, the 
goal is to utilize O2 as efficiently as possible.  The greatest athletes in the world are able 
to consume more O2 in their muscles while keeping CO2 levels low.  Once the respiratory 
exchange ratio (RER), ratio between CO2 out and O2 going in, moves above 1.1 that 
value is great enough to meet the criteria for volitional fatigue in a maximal exertion 
(VO2 max) test.   
CO2 is the driving force for respiration.  The general population will tend to 
breathe orally during exercise, which allows for faster, shorter breaths.  Shallow breaths 
lower CO2 levels, leading to upregulation, and increase the response of the CO2 receptor 
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sensitivity.  Shallow breaths will likely lower oxygenation or limit the capacity of O2 
consumption.  These effects will induce a hyperventilation response, also triggering a 
sensation of dizziness and possible fainting could occur.  Nasal breathing has shown to 
produce lower end tidal concentration of CO2 than oral breathing (Chinevere et al., 1999; 
LaComb, 2014).  Training or increasing the work capacity while nasal breathing could 
lower the CO2 demands.  Decreasing CO2 levels could increase the threshold of maximal 
exertion.    
Oral vs Nasal Breathing in Aerobic Exercise 
 Exercise physiologists focus on health and fitness in modern populations in an 
acute and chronic perspective.  In the realm of respiration there are many unanswered 
questions in the wide spectrum of oral vs nasal breathing.  Research has been completed 
at rest and during maximal bouts.  There is minimal research looking at submaximal 
intensities, particularly during running.    
Submaximal Intensities 
 Subjects were examined during 10 minutes at rest and 10-15 minutes on a cycle 
ergometer.  One test was completed using the Hans Rudolph facemask that sanctions oral 
breathing only.  On each subject’s second laboratory visit they were fitted with a nose 
facemask.  The protocol on the cycle was to maintain constant pedal rate, then a slow 
increase in resistance was administered until the subject reached a level just under 60% of 
the maximum heart rate estimated by age.  Once work rate was found, they continued at 
that constant resistance for 10-15 minutes.  During the nasal test, the protocol was similar 
with slow increases of resistance until work rate was congruent to the first test. One note 
from the author of this study is there might have been learning effects having the subjects 
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complete the study first orally, as subjects were more comfortable possibly with 
familiarity to the test.  Hall et al., (2006) found a significant increase in VO2, VE, and RR 
during exercise in oral breathing when compared to nasal breathing.  The possibility of 
the subjects learning or becoming familiarized with the protocol allowed for better 
utilization of O2, lower breath frequency and less total volume of air expended per 
minute.  During nasal breathing there was greater energy efficiency than during oral 
breathing.  Work rate and resistance were held constant on the cycle ergometer, leading 
to easier demands accomplished by means of nasal breathing in this sample size of 50 
recreational college students.   
Investigation in a different realm of the study, Hall et al., (2006), measured 
gender and anthropometric measures for conclusions to the elicited responses.  Males had 
greater nose volumes, less resistance for air to enter in through the nasal passageway.  
The larger volumes allowed for greater VO2 and VE.   There was a significant difference 
between genders in VO2 and VE during rest and exercise, for both test conditions of oral 
and nasal breathing (p<.05).  Bennett et al. (2003) found that females were significantly 
lower at VE at rest, VE at 60%, and FEV1 (p<.05).  Men had less nasal contribution to 
breathing during exercise of all intensities.  Males were able to produce greater volumes 
of air to be exchanged and expired out of the body, but the results showed less nasal 
contribution of total breathing through the nasal cavity.  Based off of these findings, the 
males in the study should have greater nasal resistance than the females.  The airway 
sizes were probably smaller or had physical limitations to nasal breathing with the 
reported low values of nasal contribution to breathing. In summary, males produce 
greater VE and VO2, due to the strength in the musculature of the diaphragm and lungs.   
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During the same study, a regression equation produced stronger predictors for 
lean body mass and body mass index (BMI) scores to levels of exercise.  The greater VO2 
in an individual would lead to a greater predictor of the actual lean body mass and BMI 
score.  Nose volume was a strong predictor for VO2, VE, and RR at a resting state.   RR 
was found to be the lone variable during exercise to be an accurate predictor from nose 
volume.  Lean body mass% was an accurate predictor from nose volume, VO2, VE, and 
nasal RR.  Overall, they found that natural selection has started to take place and there 
were strong relationships between nose volume, body size, and VO2.    
Another cycle ergometer investigation conducted looked at nasal contribution, but 
allowed access to oral breathing when desired.  Comparing: at rest up to 60% (in 10 % 
increments) of working capacity max, the investigators examined the nasal contribution 
of breathing at each intensity.  Caucasians were severely limited compared to African 
Americans in respect to nasal contribution of breathing.  African Americans produced 
25% greater maximal inspiratory flow readings (Bennett et al., 2003).   At 20% and 60% 
of max physical working capacity the Caucasians had significantly less nasal contribution 
to breathing than African Americans (p<.05),  along with a strong tendency at 40% 
working capacity of (p=.06).  Caucasians were proposed to be more susceptible to toxic 
particles due to their lack of nasal inspiration compared to African Americans. 
With knowledge of the previous research of oral vs nasal breathing at submaximal 
intensities, there were gaps in the research at the upper threshold of submaximal running.  
LaComb et al. (2014) in an unpublished study looked at treadmill exercise in college 
subjects at 50%, 65%, and 80% of their relative max.  The current investigation will 
mimic these procedures with a more reliable system.    
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Results provided evidence that RR was much lower in nasal breathing than oral 
breathing.  The ventilatory equivalents for oxygen (Veq/O2) and carbon dioxide 
(Veq/CO2) were greater in oral breathing.  Ventilatory equivalent describes the ratio of 
VE to O2 intake or to carbon dioxide output.  The end tidal oxygen (ETO2) and end tidal 
carbon dioxide (ETCO2) were also greater in all stages of oral breathing compared to 
nasal breathing.  ETO2 is concentration of O2 during the end of expiration.  ETCO2 is the 
concentration of CO2 released at the end of expiration.  Due to the greater O2 content per 
volume of air,  Veq/O2 at all intensities suggest that oral breathing was more efficient, but 
greater CO2 content expired seen in ETCO2 and Veq/CO2 during oral breathing leads to 
opposing conclusions.  Greater ETCO2 and Veq/CO2 values lead to higher CO2 values.  
When CO2 concentrations are at high enough levels, it creates a limiting factor in 
respiration.  Higher CO2 rates could initiate hyperventilation and volatile fatigue from a 
test.  When the CO2 and O2 ratio, RER, reaches levels above 1.1, which is an acceptable 
measure for maximal exhaustion in an individual.  RER rates were never in the 1.1 range, 
but there were trending up towards 1.0.   
The VO2, heart rate (HR), and ratings of perceived exertion (RPE) were similar 
between oral and nasal breathing.  Oral breathing did produce higher ventilatory 
equivalents and end tidal concentrations of both molecules portraying greater utilization 
and expired concentrations of O2 and CO2, respectively.  During exercise greater O2 
utilization is optimal, but greater expiration of CO2 leads to hyperventilation and volatile 
fatigue.  With that tradeoff it is not conclusive that oral breathing was more efficient.  
Overall, nasal breathing is an adequate mode of breathing for all submaximal intensities. 
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At 80% of an individual’s max, oral breathing is more efficient as found from the small 
population in the research.  
The metabolic cart, respiration masks, respiratory tubes, and treadmill used during 
the study were all over 15 years old.  Reliability of the previous results are in question as 
2 subjects data were exclude due to results that were outliers during the initial study and 
large variability in results of the interpreted data.  A small validity study was completed 
between the two metabolic carts that reside in the Exercise Physiology lab at UNLV, 
MPE 312.  The Orca metabolic cart was compared to the Moxus metabolic cart using the 
relative respiration masks that were specific to each system were used while maintaining 
the same treadmill use.  Six subjects were asked to complete the same VO2 max test on 
the Moxus metabolic cart as a comparative study to the Orca metabolic cart.  From the 
six individuals, VO2, VO2/kg, and VCO2 were all significantly different (p< .05) showing 
that there is a reliability issue between the two systems.  The VE and RER were trending 
to be different.  It is recommended that replication of the study on the newer, metabolic 
system be completed.   
Maximal Intensities 
Morton et al. (1995) wanted to compare the VO2 max between oral and nasal 
breathing.  Due to the greater size of the oral airway, the authors’ postulated that oral 
breathing will produce greater values.  This study asked individuals to complete five VO2 
max tests.   The first test was to acclimatize to the apparatus and protocol, along with 
completing the necessary questionnaire to determine if the individuals were susceptible to 
any asthma related issues.  The other four tests were conducted with different breathing 
modes: nasal only (Hans Rudolph allowing nasal breathing while the mouth was taped 
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closed with duct tape), oral only (Hans Rudolph face mask where the nose was clamped), 
oral and nasal (Hans Rudolph face mask with no restrictions, and mouth valve (Hans 
Rudolph 2-way non-rebreathing valve).  The VO2 max protocol included walking on the 
treadmill for two minutes at the brisk pace of 6.5 km/hr.  The intensity increased each 
minute over the next 5 minutes until it reaching a maximal speed of 12 km/hr.  After this, 
exercise intensity was increased by grade at 2% each subsequent minute until volitional 
exhaustion was reached.   
The average VE scores at VO2 max breathing nasally were reduced by 38.2%, 
35.1%, and 35.0% compared to orally in mouthpiece, Hans Rudolph mask, and oral ad 
nasal groups respectively.  Large values for reduction in VE.  The metabolic values were 
not as substantial, as VO2 max values were 13.6% (mouth valve), 11.6% (oronasal), and 
10.3% (oral breathing only) higher in oral breathing compared to nasal breathing.  The 
VE, ET O2, VO2, RR, running time and ventilation per vital capacity% (VE/VC %) were 
all significantly lower in nasal breathing compared to the other three groups (p< .05).  
ETC O2 was significantly higher in the nasal breathing trial.  HR was the only variable 
investigated that did not produce a significant difference.   
Explanations for the VO2 max differences were discussed.  The HR changes were 
minimal and since SV was not likely to be altered between the breathing modes, 
assumptions could be made that cardiac output was not the limiting factor for VO2 scores. 
The other possibility was the a-v O2 difference.  An increase in a-v O2 difference would 
allow for greater VO2 values in oral breathing.  During nasal breathing there was a 
decrease in ETO2 and increase in ETCO2.  Morton et al. (1995) proposed that saturation 
of oxygen (SaO2) would be much lower during nasal breathing due to the air remaining in 
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the lungs for a longer period of time in response to the decreased respiration rate with 
nasal breathing.  It was suggested that lower SaO2 of the arterial blood would result in 
lower VO2 values, however this measure was not obtained during the investigation.  Oral 
breathing was postulated to have greater extraction and utilization of O2 during exercise.   
Michailow et al. (1976) found a difference in VE between nasal and oral 
breathing of 51-62%.  The explanation for this observed phenomenon was that 
individuals in the study had miniscule nasal airways and large mouths.  Michailow et al. 
(1976) also reported a VO2 difference of 33.3% between nasal and oral breathing.  
Morton et al. (1995) took the study one step further by examining if there was a training 
effect according to the guideline established by the Journal of Sports Medicine (50-85% 
of VO2 max or 65-90% of maximal heart rate required to produce an increase in cardio-
respiratory endurance).  Specifically looking at the HR at 12 km/hr in each subject, 
during nasal breathing only the mean HR was equal to 87.7% of their maximal HR.  
Morton et al. (1995) did present findings that ventilatory adjustments were made to allow 
for nasal breathing to attain mean VO2 max scores of 86.5% - 90% of VO2 max found 
from other breathing modes.  In the proposed study, working at 80% of VO2 max is 
pushing the upper ventilatory threshold for an individual breathing nasally only.   
Another VO2 max study comparing oral vs nasal breathing was completed 
comparing the effects of nasal splints.  The investigation was conducted by Chinevere et 
al. (1999) and explored the nasal splinting effects on a progressive running protocol.  
Each individual completed five running trials with speed at 3.13 m/s for males and 2.68 
m/s for females, then grade increased 2.5% every 2 minutes until exhaustion.  Trials 
consisted of different modes of breathing: nasal only, oral only, nasal and oral, nasal 
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dilator, and nasal dilator and oral.  VE, Veq/O2, and RR for all nasal and nasal dilator 
modes of breathing were significantly lower than the other three modes.  Veq/CO2 was 
significantly lower for nose vs oral, and nasal dilator vs nasal, and nasal dilator vs oral 
breathing.  ETCO2 was significantly higher in nasal versus oral, oronasal, nasal dilator 
and oral, and in nasal dilator versus oral breathing.  Nasal breathing revealed a 
significantly lower HR all other breathing modes.  HR being significantly lower shows 
that nasal breathing only was not able to complete the same workload as other modes of 
breathing.  The authors postulated that lowered maximal HR values showed a limitation 
of breathing nasally at VO2 max.  The individuals were not able to complete the same 
amount of work, not allowing the body to reach the same HR while breathing nasally.   
Switching Point 
There have been studies by Ninnima et al., 1980; Campbell, 1984; Saibene et al., 
1978; James et al., 1997, measuring the switching point between nasal and oronasal 
breathing.  The original belief of researchers was that nasal breathing occurs at rest and 
oral breathing occurs during high intensity exercise.  There was small room for a 
combination, but deemed there was a set switching point between the two breathing 
modes.  The first research measured individuals wearing a facemask and the switch point 
was determined as the time when the mouth was kept open for more than 20 seconds.  
Other studies classified the switching point as a noticeable increase in VE during the 
protocol.  The effects of breathing nasally are comfortable at lower intensities, but 
generally at 35-41 total ventilation (VE) individuals switch from nasal only breathing to 
oronasal breathing (Ninnima et al. 1980; Campbell, 1984).  In effort to find the specific 
switching point, the findings are more reliant on the individuals’ breathing patterns and 
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nasal airway size.  Without a defined VE rate for all humans, there is a relative intensity 
for the specific switching point that maximizes the work capacity of the individual.   
Saibene et al. (1978) conducted one of the original investigations of the switching 
point during exercise.  During tests on 63 young cadet males, the switching point was 
determined when their mouth was kept open for 20 seconds during exercise.  The 
protocol included riding a cycle ergometer for 3 minutes stages at work loads of 98, 131, 
163, and 196 W.  Pedaling frequency was 66 rpm which was held constant due to aid of a 
metronome.  A marker was switched by a lady that sat behind the oscillograph desk when 
the individual met the criteria of the switching point.  Oronasal breathing could have 
occurred much earlier with pursed lips or the individual kept their mouth open in 
preparation for greater demands of exercise, but did not use oral breathing.  The method 
to obtain the switching point is questionable; however the results were similar to findings 
in research developed many years later.  This study found 44 l/min was the VE that the 
switching point occurred.  This was relatively high compared to what is believed to be the 
switching point today.   
Ninimaa et al. (1980) conducted a cycle ergometer test that exercised subjects 
through 0 -70% (10% increments) of their physical working capacity.  The findings were 
37% and 50% of total work capacity and 21.8 and 25 mL/kg/min VO2 in females and 
males, respectively were the switching points between the breathing modes.  The 
methods to find the switching point can happen at low levels of exercise.  In the research 
provided the switching point was found at low intensities, but lacked thorough 
investigation about the set switching point being the necessary moment oral breathing or 
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cessation of exercise would result.   For the general population nasal breathing is not 
commonly practiced.   
The percentage of work capacity was lower than anticipated, a small percentage 
of subjects could withstand work at 196 W on a cycle ergometer breathing nasally only 
(Saibene et al., 1978).  Ninimaa et al. (1980) noted roughly 20% of the subjects were able 
to complete all submaximal intensities breathing nasally with work output up to 110 W.  
Nasal breathing can be more comfortable for certain individuals with less nasal resistance 
and an adequate mode of breathing during all submaximal exercise.  The switching point 
had a high predictive value (69.8%) to ratings of perceived exertion of breathing and total 
VE in nasal breathing.    
Ninimaa (1981) replicated the cycle ergometer protocol, but tested oronasal 
distribution of respiratory airflow.  The findings of this study were that the switching 
point occurred at 45 L/min and accounted for 61% of total VE at high respiratory 
volumes.  The nasal inspiration of oral breathers exceeded expiration by 2 L/min at rest, 
but the difference increased to 13.5 L/min at a VE of 81.5 L/min.  With work from the 
previous study there was bias towards early shifting of oronasal breathing and the need 
for oral breathing earlier.  The replicated study showed nasal breathing was adequate at 
rest and comfortable.  During the higher demands of exercise oral breathing was 
dominant as was suspected.   
A study was conducted by James et al. (1997) examining the switching point in 
various ages during a submaximal exercise test.  The results were as follows: 7-72 years 
old, nasal only (13.5%), nasal shifting to oronasal (40.5%), oronasal only (40.5%), and 
oral only (5.4%).  The majority (81%) of runners breathed nasally at lower levels and 
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switched to an oronasal breathing pattern.  Nasal airway resistance decreased 
significantly with age (p < .001).  Adults ages 17-30 that started breathing nasally with 
exercise switched to oral ventilation at a lower percentage of the earlier measured 
maximum ventilation (10.8%) than older subjects (31.8%).   Ventilation patterns during 
exercise in children ages 7-16, displayed more variability than adults.  Overall with the 
wide variety of subjects, with mixed genders, age, and ethnicity, there were no accurate 
predictors between the switching point or ventilation rates.   
Competitive Race 
Ninimaa (1983) studied 984 participants in a 10 km fun run.  Subjects were 
videotaped using a Sony Betamax SLO 340 at the 9000 m mark while running towards 
the camera.  Elapsed time was also recorded on the recorder.  The degree of mouth 
opening based off of video playback were determined in 7 characteristics’: mouth closed, 
lips possibly sealed, mouth open, mouth open teeth not occluded, mouth open not sure if 
teeth occluded, moth open and closed in rhythm with breathing, and subject discarded.  
Of the 917 people that were able to be analyzed, 96.3% of them were classified as 
oronasal breathers.  The video recorder found 3 individuals to be predominantly nasal 
breathers.  The three nose breathers (all males) ran at a much slower pace than the 
average male.  There were no findings between larger openings of the mouth, correlated 
with running speed and increased pulmonary ventilation as the study hypothesized.   .   
High Intensity Exercise 
 In an abstract, recently published by Meir et al. (2014) nose plugs were worn to 
see the physical demands in oral vs nasal breathing.   There were no differences in the 
time to completion, blood lactate, VE, HR, and RPE when wearing the nose clip.  The 
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individuals were able to achieve the same amount of work while completing all out 
shuttle runs independent of which breathing mode they were using.  Exercise consisted of 
only 20m shuttle runs lasting less than 30 seconds, there were no differences in 
performance or respiratory values in the study.    
Walking Intensities 
During a six minute walking test in children SaO2 were lower in the oral breathing 
group compared to the nasal breathing group.  Children with oral breathing showed 
significant increase in RR; decreased saturation rates and lower ratings on the Borg scale 
(Boas et al., 2013).  Milanesi et al. (2014) found subjects that were diagnosed as oral 
breathers or nasal breathers as children. Subjects were 18-30 when completing the study, 
but were diagnosed having a specific characteristic of predominantly breathing nasally or 
orally.  After a 6 minute walk test, the study produced significantly lower maximal 
expiratory pressure in oral breathers compared to nasal breathers (p<.05).  After years of 
chronic mouth breathing, the group produced much weaker expiratory pressure.  This 
study provided evidence pointing to a detriment for breathing mostly through the mouth 
as a child and never adapting or initiating the attempt to breathe nasally.    
Step Test 
Individuals assessed during a step test breathing nasally versus orally were 
measured by Richerson and Seebohm (1968).  Nasal resistance decreased as the step test 
became more difficult.  In effort to look at the mechanism for this action: norepinephrine, 
epinephrine, phentolamine HCL, guanethidine, and stellate ganglion block were given on 
separate occasions.  Norepinephrine and epinephrine elicited no response to exercise.  
Phentolamine and stellate ganglion block were found to severely congest and close the 
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nasal airway (Richerson and Seebohm, 1968) and the step test was ceased due to the 
problems of nasal congestion.  Most subjects did experience increased nasal airway 
openings 15 to 30 minutes following the step test.   
Nasal Size and Resistance 
The nose provides 2/3 of the resistance in the respiratory tract (Swift, 1988), 
consequently the size of the nasal cavity is the largest contributor to the switching point.  
The larger the nostrils and size of the nasal cavity the longer, individuals were able to 
breathe through the nose (Ninimaa et al., 1980).  An individual with a nasal airway less 
than 0.4 cm2 was known to have airway impairment and unable to sustain nasal breathing 
beyond the desired work capacity, which occurred in roughly 12% of the subjects 
(Warren 1988).  If the nasal passageway is smaller than 0.4 cm2 then the individual will 
rely on oral breathing.   
The nose acts as a filter in respiration, preventing the penetration of toxic particles 
and gases to the lower respiratory tract.  In different modes of breathing (nasal vs. oral) 
there may be differing effects of amounts of toxicant doses to the lungs.  Different ethnic 
groups have anatomical differences, leading to certain populations to have improved 
responses of nasal breathing over others.   Chinese individuals have greater nose cross 
sectional area than Indians and Caucasians (Zhu et al., 2011).  Bennett et al. (2003) found 
that Caucasians had less nasal contribution in breathing during submaximal exercise than 
African Americans (p <.05).  Maximal inspiratory flow was 2.1 L/s for Caucasians and 
2.8 L/s in African Americans.   Adaptation has played a key role in nasal airway size.  
Depending on where the individual is located and climate, there may have been 
adaptations to the nose.  A tall, long nose with downward directed nares will help in 
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cooler climates, allowing for more time and space for the air to be warmed and 
humidified.  The longer nose experiences greater turbulence of airflow and has a greater 
surface area for exposure of harmful toxicants to the mucus membranes.  A broader nose 
will more than likely reside in a more humid climate, to scatter and dissolve particles 
before it enters the lower respiratory tract (Churchill et al., 1999).   
Bennett et al. (2007) completed another study that mimicked the gender 
comparison of nasal contribution to breathing. This change was looking at different ages: 
children and adults.  Children will have lower nasal contribution to breathing at rest and 
during exercise than adults. Children however, have significantly decreased nasal 
deposition efficiency for 2-μm particles under light exercise breathing conditions 
compared to adults.  Based off of these findings, children are less efficient at nasal 
filtering for larger particles and higher flow conditions. These results suggest that the 
lungs of children may be exposed to higher concentrations of inhaled, ambient particles 
than adults.   
Exercise decreases nasal airway resistance within 30 seconds and could persist 
from 5-30 minutes.  Immediately the nasal airway creates a response to exercise.  
Allowing for this response creates the ability for nasal breathing at high demands of 
exercise in short time constraints.  That would cause an issue if nasal resistance would 
not decrease until 5-10 minutes after the initiation of exercise.  Due to the immediate 
physiological response nasal breathing is proposed to be more efficient during low to 
moderate levels of exercise intensity.  Nasal airway resistance drops in proportion to 
exertion, with a 39% reduction at workload of 75 watts and 49% after 100 watts (Forsyth 
et al., 1983).  This response is primarily a result of reduced blood flow and blood content 
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of the nasal mucosa.  This mechanism may be adaptive to allow improved ventilation or 
redistribution of nasal blood to the muscles, heart, and skin (Schulz and Horvath, 1989).  
Increased blood flow to other parts of the body during exercise will help utilize the 
necessary molecules for optimal performance.   
Decongestant sprays are great psychological aids for aerobic competitors.  
Allowing the nose to feel free of any resistance pre-race or before a training session.  
Decreasing resistance will increase the ability for air to travel into the nasal passageway 
and into the lungs.  Benninger et al. (1992) compared the effect of a nasal spray on 
aerobic performance.  During a cycle ergometer test there were no differences during the 
exercise testing.  The VO2, HR, VE, and FEV1 all produced no statistically significant 
differences.  Pre-exercise nasal resistance was lower in the nasal spray condition than all 
other test groups.  The nasal spray, oxymetazoline hydrochloride, provides no aerobic 
benefits, but decreases nasal resistance immediately (Benninger, 1992).   In a separate 
study measuring peak nasal inspiration flow by means of doses of oxymmetazoline, 
higher doses resulted in less nasal resistance (Clarke et al., 1994).  The drug works, but it 
plateaued showing the similar results as the previous study in terms no exercise response.   
Nasal VE accounted for 27% at 90% of the maximal attainable power (Fregosi 
and Lansing, 1995).  Wheatley et al. (1991) found that 36% of total VE at maximal work 
occurs nasally.  Despite majority of work accomplished by oral breathing, up to 1/3 of the 
work is completed by nasal breathing.  Nasal VE and integrated nasal flaring EMG 
activities increased linearly with intensity up to 60% of the max power (Fregrosi and 
Lansing, 1995).   However, both variables plateaued at 60% of work capacity.   This 
leads to analyze that nasal breathing can be an adequate mode of breathing up to 60%.  At 
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that point, there is a plateau effect, due to the inability of the nasal airway to expand or 
increase volume of air anymore.  As humans we are restricted on how large the airway 
can become.  In the sample provided in this study, individuals were not able to increase 
their abilities of nasal VE or nasal flaring past 60% of their work capacity, but up to that 
point was a sufficient mode of breathing.  Conclusions based off of these findings include 
the exponential rise in nasal VE and nasal flaring represent the turbulent flow produced in 
the nasal airway.   Nasal airway is restricted in the full capacity of the body’s needs.  
There are limitations and once those limitations are met, oral breathing is necessary for a 
switch to occur.   
Nasal Reflexes 
 The brainstem, autonomic, and systemic reflexes that regulate nasal airways 
regulate our breathing.  They are in control of every sensation and reflex that occurs 
through the mucosal passages of the bronchioles.  Sympathetic reflexes are active in the 
nasal mucosa in forms of baroreceptors.  Baroreceptors control blood pressure and blood 
flow.  Nasal resistance decreases immediately after exercise, as the intensity of exercise 
increases there will be an even greater decrease in resistance of the passageway.  
Sympathetic vasoconstriction in the nasal cavity is a response of the sympathetic effect to 
maintain flow of oxygenated blood to the muscles (Baraniuk and Merck, 2008).  The 
response for vasoconstriction will occur during high work rates.  In an opposite spectrum, 
a normal parasympathetic response is vasodilation.  The parasympathetic nervous system 
works as an antagonist to the sympathetic nervous system.  The efforts of the 
parasympathetic nervous system are to decrease blood pressure, decrease heart rate, and 
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promote a rested state.  If both systems are stimulated simultaneously, the sympathetic 
will override.    
 Nasal and sinus patency increases from exercise and adrenergic agonists.  
Richerson and Seebohm (1968) found that intravenous infusion of epinephrine and 
norepinephrine did not stimulate a response to exercise.  There was a significant blockade 
with topical phentolamine and stellate ganglion block.  It was presumed that 
phentolamine played a key role in a blocking effect in the sympathetic nerve ending.  
Stellate ganglion block resulted in sympathetic paralysis and promoted a sympathetic 
nerve discharge.  Blocking the sympathetic effect increased nasal resistance and induced 
congestion in the participants.     
 During asthma attacks nasal breathing can induce bronchodilation.  With nasal 
breathing, sniff and gasp-like maneuvers can reverse the sensation of breathlessness.   
Stopping an asthma attack with nasal breathing and initiated reflex techniques could 
make the difference of life or death.  Complete bronchoconstriction will stop air passing 
through the bronchioles.  The only airway available would be the nasal passageway.  
Increasing nasal breathing during this mechanism can lower the asthmatic response and 
alleviate further problems.  Zomori et al., (2000) showed reversal of apnea by means of 
sympathetic activity and contribution of gasping and sniffing to resuscitate the 
individuals.  Adrenergic reactions mediated by catecholamine secretion and allowed 
regular breathing to transpire.  
Nasal Dilator Strips on Nasal Breathing 
Nasal dilator strips are banned by athletic committees, due to the effect they have 
as an ergogenic aid on aerobic based sports.  The purpose of the nasal dilator strip is to 
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decrease the nasal cross sectional area by dilating the nostrils. A nasal dilator strip 
stiffens the lateral nasal vestibule walls.   Having less resistance in the passageway will 
allow for greater exchange of air.  Another positive benefit for nasal strips is prevention 
of nasal flaring, where the nostrils decrease in size or completely close the airway.  The 
dilator strips help individuals with sleeping and reduce nasal airway resistance.   
The benefits of nasal strips could enhance nasal breathing over any other mode of 
breathing.  The strongest indicator of augmented breathing due to nasal strips is VE.  
Decreasing resistance of the nasal passageway should increase the total VE in the nasal 
passageway when wearing a nasal dilator strip.  While using a nasal dilator strip in 
Oriental subjects the nose contributes to 80% of VE during mild exercise and drops to 
45% during near maximal treadmill running (Liu and Mafarlane, 2001).   During lower 
intensities the nasal contribution of breathing is much greater than during higher 
intensities.  At submaximal intensities or roughly 30 mL/kg/min in healthy individuals 
Chinevere et al. (1999) found VE to be quite similar when comparing oral vs nasal 
breathing.      
There have been mixed results with performance enhancements on VO2 max as a 
result to wearing the nasal dilator strip.  A few studies showed small improvements 
(MacFarlane and Fong, 2004; Gehring et al., 2000; Griffin et al., 1997), while others 
found no difference (Chinevere et al., 1999; O’Kroy, O’Kroy et al., 2001; Overend et al., 
2000; Nunes et al., 2011).  Nasal dilator strips will likely enhance aerobic performance in 
a few individuals, but has not been found to produce significant benefits in all people.    
The SaO2 is the percent of O2 that is saturated with hemoglobin.  The normal 
SaO2 rate is between 95-100%.  Exercise-induced arterial desaturation was increased due 
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to the use of a nasal dilator strip (Martin and O’Kroy, 1993).  With greater nasal 
breathing as a response to use of a nasal dilator strip, the saturation rates were lower in 
individuals using the ergogenic aid.  The lower RR (LaComb, et al., 2014; Chinnevere et 
al., 1999) during breathing must translate to less arterial O2, therefore utilizing more O2 
when they become available which results in a decreased saturation rate.   
A different performance based benefit found when wearing the nasal strips is 
ratings of perceived effort was significantly reduced with the strip (MacFarlane and 
Fong, 2004; Tong et al., 2001).  In respect to aerobic performance there are slight 
advantages to using a nasal dilator.  An aid that will keep the nasal airways dilated can 
improve performance, but minimal improvements are seen at best.  Both studies used a 
placebo, but anecdotal experience with nasal dilator strips has shown that the nasal 
airways are kept open.  There might have been a psychological benefit to the strip 
because the individuals knew which strip was decreasing the nasal resistance.   
Using a nasal dilator strip on anaerobic tests the results are mainly negative.  
Tong et al. (2001) found a reduction in ventilatory muscle fatigue, but increases in 
maximal power output.  Macfalane and Fong, (2004) found no significant difference 
between short anaerobic power and long term anaerobic power tests.  Boggs (2008) found 
no significant difference in the blood lactate concentration.  Anaerobic effects with use of 
a nasal dilator do not provide the same possible benefits when compared to aerobic 
benefits.    
For individuals given an opportunity to train with a dilator strip, VO2 performance 
can improve and might lower their perceived work rate.  Results are mixed, but elite 
endurance athletes any benefit with the minimal performance increase.  Training with 
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nasal dilators and adaptation to nasal breathing would be an advantageous physiological 
adaptation.  For individuals that may have issue breathing nasally, a nasal dilator strip 
could be an excellent alternative to improve nasal respiration. 
Respiratory Problems 
 Nasal vs oral breathing has been explored in numerous respiratory illnesses.  
Nasal breathing shows benefits and can lead to prevention or reduce the problems in 
individuals with respiratory illnesses.  Certain issues that have been researched include: 
bronchoconstriction, asthma, COPD, sleep apnea, and snoring.  Researching the effects of 
nasal vs oral breathing in individuals with all of these diagnoses is not an area in which I 
am educated or desiring to do, but if I can find a basis for increased performance in nasal 
breathing in moderate exercise conditions, that could strengthen the effects toward 
helping these subjects out.   
 Bronchoconstriction is a constriction of airways in the lungs from smooth 
muscle contractions.  This definition is broad and fits many mechanisms.  The 
constriction occurs from tightening of the smooth muscle that surrounds the bronchioles, 
with normal responses of coughing, wheezing, and shortness of breath.  Nasal breathing 
can reduce the effect of exercise induced bronchoconstriction with athletes (Parson and 
Mastronarde, 2005).  Despite the conditioning or activity level, all individuals should 
have a concern for bronchoconstriction.  High demands of exercise with oral breathing 
can increase the likelihood of the response.  Overuse of the thoracic muscles and 
diaphragm cause fatigue and problems within the bronchioles.  During high intensity 
coupled with oral breathing, there is a greater likelihood for bronchoconstriction.  When 
air travels through the oral cavity only, it skips by the nasal mucosa completely, never 
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being filtered, warmed or humidified before entering the respiratory tract.  Increasing 
nasal breathing is one suggested immediate response to limit the bronchoconstrictive 
responses in over 10% of the general population.   
Exposure to cold air increases resistance in the pharynx, specifically through the 
mouth.  Breathing in cold air, can alter the capacity of the oral cavity during exercise.  
Nasal breathing on the other hand will be affected by extreme cold temperatures likewise, 
but the nose can warm the air when traveling through the nasopharynx.   Nasal breathing 
can warm the air up to 3°C (Swift, 1982).  Cold air breathing through the oral cavity can 
lead to bronchoconstriction responses.   Anyone can be susceptible to 
bronchoconstriction, even the physically elite have problems with exercise induced 
bronchoconstriction (EIB).  Parson and Mastronarde (2005) found that up to 26% of all 
Olympic winter sport athletes in 2000 and up to 50% of cross country skiers have EIB.   
Measuring the effect of nasal and oral breathing on asthmatic or non-asthmatic 
individuals led to promising results for nasal breathing.  The participants were asked to 
run on the ground with their nose or mouths covered, then later try the other protocol.  
The groups were five asthmatics with exercise liability, five asthmatics with no liability, 
and 5 healthy individuals.   Flow rate was measured before, after, and 5, 10, 15, 20, and 
30 minutes post exercise.  If the FEV1 was 20% or more from the basal levels then there 
was evidence bronchoconstriction.  Mangla (2006) found a significant difference (p<.05) 
with post exercise FEV1 rates between oral versus nasal breathing.  When the participants 
were directed to breath only through their nose there was a markedly different post-
exercise bronchoconstrictive response.  Asthmatic individuals can benefit from training 
nasally.   
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In the first step of a study of the relation of nasal and oral breathing during 
moderate treadmill exercise to the onset of bronchoconstriction in young patients with 
perennial bronchial asthma, it was observed that most subjects normally breathed with 
their mouths open when instructed to breathe "naturally." Subsequently, when they were 
required to breathe nasally during the exercise, an almost complete inhibition of the post 
exercise bronchoconstrictive airway response was demonstrated.  During exercise with 
oral breathing only an increased bronchoconstrictive airway response occurred, as 
measured by spirometry, flow-volume relationships, and body plethysmography. These 
findings suggest that the nasopharynx and the oropharynx play important roles in the 
phenomenon of exercise-induced bronchoconstriction (Shturman et al., 1978).  Overall, 
bronchoconstriction will last 5-10 minutes after exercise and up to 30 minutes if no 
bronchodilator is administered (Bruno et al., 1994).  Nasal breathing will not fix the issue 
of post exercise response with bronchoconstriction, but could reduce the impact of the 
response.   
 With these individuals dealing with respiratory problems, sleeping at night with 
their mouth closed 36 out of 50 participants felt comfortable with breathing primarily 
through the nose.  Numerous asthmatics produced positive responses with 11 of 50 
feeling improved sleep quality, 16 felt reduced snoring, 13 felt fresher upon waking, and 
13 felt their asthma improved (Cooper, 2008).  Overall, nasal acclimatizing to nasal 
breathing in multiple populations could provide physiological benefits.  
 There are numerous respiratory problems and nasal breathing alone will cure all 
solutions.  A few studies mentioned previously elicited the closing of the airway and a 
sensation of loss of breath.  That is a scary feeling for an individual to attempt to gasp for 
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air, but nothing will enter the body due to a closed airway.  At moments like that the 
reaction is to bring in the greatest amount of air possible through the oral cavity.  During 
this respiratory problems, that is where the underlying problem exists and air should be 
attempted to be inspired through the nasal airway.  Having individuals experience more 
nasal breathing at rest, exercise, and during times of distraught, nasal breathing could 
produce a greater benefit then oral breathing.  The worst thing to occur is panic and force 
inspired air through the mouth only.  Stay calm and take a deep, long slow breath through 
the nose and the issues might relieve themselves.   
Nitric Oxide 
Nitric oxide (NO) was first demonstrated through exhaled air.  Gustafsson et al. 
(1991) first discovered in exhaled breath on experimental animals.  Originally, NO was 
inhibited by multiple enzymes, but through experimentation NO synthesis occurred with 
L-arginine supplementation.  When NO was confirmed in the presence of exhaled air, 
there were multiple studies conducted upon responses of exhaled NO.  The occurrence of 
NO was first believed in the lower airways and lungs, but Alving et al. (1993) found high 
concentrations of exhaled NO in healthy subjects originated in the upper airways, 
primarily the paranasal sinuses and nasal cavity.   
Physiological actions of NO include the regulation of vascular tone and blood 
pressure, prevention of platelet aggregation and inhibition of vascular smooth muscle 
proliferation.   
There are differing opinions on the origin of NO.  Multiple studies have expressed 
the contribution of endothelium and macrophages in the lungs, pulmonary vascular 
endothelium, but also from the small airways of the terminal and respiratory bronchioles 
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as the source.   Others have found the upper airway like the nasal mucosa as the 
origination of NO.  Nasal breathing produced roughly double the NO compared to oral 
breathing at rest and submaximal exercise (Yasuda et al., 1997).  The prevalence in NO 
during nasal breathing yields the physiological benefit to exist during nasal breathing.  
Producing the same response or amounts of NO will not be possible in each individual, 
but would create a performance advantage.  Improving nasal breathing and conditioning 
to decrease CO2 exhalation and lead to greater NO production, coupled together, higher 
O2 utilization could occur as a positive training effect over time.  Along with other 
cardiorespiratory responses, NO concentrations were found to increase with physical 
conditioning levels (Maroun et al., 1995).   Individuals capable of obtaining higher HR 
during exercise on a stationary bicycle produced rapid increases in pulmonary NO 
excretion rate.  The NO excretion rate during exercise was highly correlated with 
observed changes in heart rate (p < .001) (Bauer, 1994).   
Even holding your breath for thirty seconds can produce higher NO concentration 
exhaled from the nasal airways compared to normal exhalation from the mouth.  (Martin 
et al., 1997).   NO is synthesized in various types of cells, including the endothelium, 
macrophage, neutrophil, epithelium, autonomic nerves, etc., and is involved in many 
physiological functions relating to the control of vascular tone, non-specified immunity, 
neurotransmission, etc.  (Yasuda et al., 1997).   Total NO output in the exhaled air of 
humans was found to increase with increases in exercise intensity in all individuals.  
Inhaled NO by a through the nasal cavity can produce six times fractional inhaled NO 
concentration than oral inhalation (Tornberg et al., 2002).  The inhalation levels found in 
the Tornberg study were sufficient to improve oxygenation.   Would need a cannula to 
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obtain the amounts of NO, but could provide physiological benefits.  Inhaled nitric oxide 
appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary 
vessels in better-ventilated areas of the lung, moving pulmonary blood flow away from 
lung segments with low ventilation/perfusion (V/Q) ratios toward segments with normal 
or better ratios (Ballard et al., 2006).  The fractional concentration of exhaled NO 
(FENO) in healthy children appeared to be affected by race, age and height (Kovesi et al., 
2008).  Greatest significance between exhaled NO concentrations were found between 
Asian-Canadian children and African-Canadian children (p < .001).  The (FENO) rose 
slightly with age (p=.07) and with height (p < .05) in the patients with pulmonary 
hypertension, PVR fell significantly after inhaled NO and after prostacyclin.  Inhaled NO 
therefore seems to be both a selective and effective pulmonary vasodilator. (Pepke-Zaba 
et al., 1991). 
Summary 
 Oral breathing is necessary at higher demands of exercise eliciting a greater 
capacity for the individual to complete a maximal workload.  During submaximal 
intensities nasal breathing can provide small intricate benefits that could lead to adequate 
exercise.  The mode of breathing that will complete more efficient work upon the body is 
the dilemma that is desired to be answered.  
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Chapter 3 
METHODOLOGY 
Subject Characteristics 
There were 23 individuals that were recruited to participate in the study.  A total 
of 19 individuals (men N=9, women N=10) completed the entire protocol, two failed the 
nasal breathing test, and two individual subjects dropped out.  Descriptive statistics are 
described in Table 1. 
Table 1: Anthropometric measures of subjects 
 Male Female 
N 9 10 
Age (yrs) 25±7.4 24±3.0 
Height (in) 70±1.7 66±3.1 
Weight (lbs) 185±18.9 146.5±17.0 
Body Fat % 16%±6.4 27%±6.3 
 
Each subject completed the ACSM health risk questionnaire, and signed an 
informed consent document. Subjects had to be in a "low risk" category according to the 
ACSM health risk questionnaire. If the participants were able to answer "None of the 
above" on the questionnaire, check nothing in the first section (history, symptoms, other 
health issues), or check no more than one cardiovascular risk factor, and were a male 
younger than 45 years of age or a female younger than 55 years of age, they will be 
considered "Low Risk" according to the ACSM algorithm, and were able to participate in 
the investigation. The ACSM criteria for low risk includes men younger than 45 years of 
age and women younger than 55 years of age who are asymptomatic and meet no more 
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than one risk factor threshold for coronary artery disease risk. Subjects were excluded 
from the study based on the following criteria: (a) Currently pregnant (b) Subjects with 
implantable devices such as Pacemaker, Automatic Implantable Cardioverter 
Defibrillators (AICD) (d) Orthopedic (Acute or chronic musculoskeletal injury), 
cardiovascular (coronary artery disease), respiratory (Chronic Obstructive Pulmonary 
Disease or Asthma), metabolic conditions (Diabetes), and current smoker. Current 
smoker is defined as someone who currently smokes or who has quit less than six months 
previous.  
 
Collection of Data 
Subjects were instructed to wear loose fitting clothing (i.e. shorts, t-shirt, and 
running shoes) and to report to the Exercise Physiology Laboratory (MPE 326) on three 
separate dates.  The individuals were instructed to be well hydrated, consume their last 
meal at least 2 hours prior to testing, refrain from caffeinated beverages for 2 hours prior 
to testing, and to refrain from alcoholic beverages for at least 6 hours prior to the test. 
Participants were asked to refrain from strenuous physical exercise during the day prior 
to testing. Prior to exercise testing, subject's body weight, height, and body composition 
were measured using a Total InBody 720 Body Composition Analyzer (InBody Co., 
Biospace, Seoul, Korea).  Prior to the test, each subject was instructed on the use of 
Borg’s 6-20 Rating of Perceived Exertion scale (RPE).  The graded exercise test protocol 
(GXT) was performed on a standard treadmill (Precor C954/C956, Precor Incorporated, 
Los Angeles, CA) with metabolic data being collected using a Moxus metabolic System 
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(AEI Technologies, Pittsburg, PA, USA).  The Moxus was calibrated each day of testing 
that occurred in the exercise physiology lab.     
A V2 Hans Rudolph respiratory facemask (Hans Rudolph Inc., Shawnee, KS, 
USA) was used for all respiratory metabolic measurements. A heart rate monitor was 
applied to the participant’s lower sternum under their clothing during all protocols (Polar 
Electro Inc., Lake Success, NY, USA).  Participants completed the progressive exercise 
test either to the point of volitional fatigue or until a research team member decided to 
stop the test due to physical manifestations of severe fatigue.  The criteria for a subject 
attaining VO2 max will be meeting at least two of the following conditions: termination 
due to volitional fatigue, respiratory exchange ratio of 1.10 or greater, heart rate within 
10 beats per minute of the age-estimate maximal (heart rate maximal = 220-age), or 
rating of perceived exertion greater than 19 on the Borg scale.  
The first session was a VO2 max with the design to measure the voluntary 
switching point from oral to nasal breathing.  The individual was instructed to breathe 
only through the nose, until they were not able to do so comfortably anymore.  When the 
individual felt they needed to “switch over” or use both breathing modes they were 
instructed to raise their hand.  The VE at the moment their hand was raised was deemed 
the switching point.   The protocol for the VO2 max was 3-min of treadmill walking at 3 
mph, increase to 5 mph for one minute, with further increases in speed by 1 mph each 
minute thereafter.  On the other two sessions (one oral breathing, one nasal breathing, 
counterbalanced), subjects were asked to complete a submaximal treadmill protocol 
running at 50%, 65% and 80% of their VO2 max for 4 minutes in each stage.  Running 
speeds were determined using a regression equation based on the speeds and VO2/kg 
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values from the first session.  The predicted speed was relative to the individuals results 
from the first test.  The submaximal protocol consisted of 12 minutes of running unless 
the subject was not able to complete the test.  After 2, 3, and 4 minutes of each stage RPE 
and SaO2 were collected.  SaO2 was collected using a Pulse Oximeter (Shenzhen Creative 
Industry Co., Shenzhen, China) that was taped onto the finger.  On sessions 2 and 3 a pre 
and posttest FEV1 measure was taken using a MIR MiniSpir Light Spirometer (MIR 
Medical International Research, Maggiolino, Roma, Italy).  The subjects were measured 
at rest and within 20 seconds post exercise.  The FEV1 test instructions were to take a 
huge deep breath in, then exhale all air out of the lungs while having the spirometer 
enclosed by the mouth to obtain the proper readings.  The individual was instructed to 
help take off one part of the respiratory mask to help take the FEV1 measure within 20 
seconds of completion of the test.   
 
Statistics 
Data analysis was collected on the Moxus during all sessions measuring: RR, VE, 
VO2, VCO2, RER, HR, Veq/O2, Veq/CO2, VO2/kg and SaO2.  RPE, FEV1, and SaO2 
were taken manually as they were separate from the Moxus.  The steady state values were 
used in analysis, the respected values at 2, 3, and 4 minutes.  A 2x3 repeated measures 
analysis of variance (RM ANOVA) test and simple main effects analysis were conducted 
to compare the oral vs nasal breathing modes at the three different intensities.  A paired 
sample t-test was completed between pre and posttest to compare the FEV1 values.   
Significant results were determined using an alpha level of p<.05.     Analysis was 
  
41
conducted using the Statistical Package for the Social Sciences (SPSS version 22, IBM 
Corporation, Armonk, NY) software.   
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Chapter 4 
RESULTS 
Findings 
 Below is a table with all the measures means and standard deviations displaying 
both breathing modes across the three different exercise intensities.   
 
Table 2: Means and standard deviations of measures during submaximal intensities in 
both breathing modes 
 
Oral Nasal 
Intensity 50% 65% 80% 50% 65% 80% 
HR (b/min) 132±11.6 157±9.7 175±10.0 132±13.6 151±16.8 166±19.8 
RR (br/min) 33.3±8.1a 41.0±9.4b 50.5±10.9c 25.3±7.0a 32.6±7.3b 38.6±7.3c 
VE (L/min) 43.4±12.8a 60.2±13.4b 76.9±17.5c 36.1±10.7a 48.2±11.0b 59.3±14.2c 
RER 0.85±.06a 0.92±.04b 0.98±.04 0.80±.08a 0.88±.07b 0.95±.08 
VO2/kg(mL/kg) 29.7±6.6a 38.3±4.0b 44.5±4.0c 26.8±6.0a 34.9±3.7b 40.9±5.0c 
VO2 (mL/min) 2250±603a 2900±534b 3371±627c 2051±632a 2657±583b 3114±704c 
VCO2 (mL/min) 1924±573a 2684±524b 3296±614c 1677±613a 2354±629b 2979±814c 
Veq/O2 (L/mL) 19.3±1.9 20.8±2.5b 22.9±3.2c 18.0±2.8 18.2±1.8b 19.1±2.3c 
Veq/CO2(L/mL) 22.8±2.7 22.5±3.1b 23.4±3.4c 22.5±3.9 20.8±2.3b 20.3±814c 
RPE 9±1.7 12±1.8 15±2.0 10±2.5 12±2.2 15±2.3 
SaO2  96%±1.5% 94%±2.8% 93%±2.6%c 95%±4.1% 93%±4.5% 91%±3.6%c 
a: Significant difference between the two breathing modes at the 50% work intensity 
b: Significant difference between the two breathing modes at the 65% work intensity 
c: Significant difference between the two breathing modes at the 80% work intensity  
  
43
There was a significant interaction between intensity and breathing mode when 
respiratory rate was considered (p<.001). The results for RR were significantly greater in 
all exercise intensities during the oral breathing mode, compared to the nasal breathing 
mode (see Table 2 and Figure 1).  Oral and nasal breathing produced a 34% change in RR 
between the 65% and 80% intensities, but the starting RR for oral breathing 
was33.3±8.1br/min and 25.3±7.0 br/min for nasal breathing.   
  
 
Figure 1: Respiration rates during submaximal intensities 
 
There was a significant interaction between intensity and breathing mode in the 
RM ANOVA factorial analysis (p<.001). VE was significantly lower at each exercise 
intensity when subjects performed nasal breathing, compared to oral breathing (see Table 
2 and Figure 2). The difference between breathing modes tended to increase as exercise 
became more intense (50% ∆ = 16%, 65% ∆ = 20%, 80% ∆ = 23%, see Figure 2).   
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Figure 2: Ventilation rates during submaximal intensities 
 
Interaction was significant between intensity and breathing mode when RER was 
measured (p<.001).  The findings for RER were significantly greater in the two lower 
intensities (50% and 65%) in nasal breathing, compared to oral breathing (Table 2).  The 
most strenuous exercise intensity had no significant difference with RER despite nasal 
breathing being .03 lower (oral = 0.98±.04, nasal = 0.95±.08).   
There was a significant difference in all three exercise intensities between the two 
breathing modes in VO2/kg, VO2, and VCO2.  With VO2/kg there was an 8-10% decrease 
in nasal breathing, when compared to oral breathing in all intensities as seen in Figure 3.  
VCO2 produced a 7-9% decrease in the nasal breathing mode, compared to the oral 
breathing mode (Table 2).  VCO2 produced changes (50% ∆ = 13%, 65% ∆ = 10%, 80% 
∆ = 10%) as seen in Table 2.  The measures VO2/kg, VO2, and VCO2 all had significant 
interaction at intensity and breathing mode with 2x3 RM ANOVA (p<.001). 
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Figure 3: Relative VO2 rates during submaximal intensities  
 
The Veq/O2 and Veq/CO2 were significantly higher in the oral breathing mode 
during the latter two intensities, compared to the nasal breathing mode (Table 2).  Oral 
breathing produced greater differences as the exercise intensity level increased.  During 
the various intensities of 50%, 65%, and 80% of the individuals VO2 max the 
significance between the two breathing modes in Veq/O2 became higher as the exercise 
increased (50% ∆ = 7%, 65% ∆ = 13%, 80% ∆ = 17%) seen in Figure 4 and for Veq/CO2 
was (50% ∆ = 1%, 65% ∆ = 8%, 80% ∆ = 13%)  as shown in Figure 5.  The Veq/O2 had 
a significant interaction with intensity and breathing mode (p<.001) while the Veq/CO2 
did not produce significant interaction (p=.775).  Despite Veq/CO2 having no interaction 
there was significant results with simple main effect analysis with intensity and breathing 
mode both producing probabilities of p<.05.   
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Figure 4: Ventilatory equivalent for oxygen rates during submaximal intensities  
 
 
Figure 5: Ventilatory equivalent for carbon dioxide rates during submaximal intensities  
 
There was a significant interaction between intensity and breathing mode when 
oxygen saturation was considered (p=0.034).   Oxygen saturation resulted in lower 
percentages in the 80% intensity only.  The nasal breathing test significantly lower in 
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SaO2 values at the last exercise intensity, compared to oral breathing (p=.035) as shown 
in Table 2 and Figure 6.  There was no statistical difference in SaO2 during the first two 
stages.   
 
 
Figure 6: Saturation of oxygen rates during submaximal intensities  
 
There was no significant difference in HR or RPE during this investigation. HR 
began to trend towards lower values with nasal breathing in the last intensity.  The 80% 
exercise intensity produced a HR of 175±10.0 b/min for oral breathing and 166±19.8 
b/min for nasal breathing, but was not significant (Table 2).  There was greater variance 
or standard deviation in the nasal breathing mode.  RPE produced comparable data 
throughout all intensities.  The RPE scores were similar in both breathing modes 
throughout all intensities.  Between the three intensities of 50%, 65%, and 80% oral 
breathing 9±1.7, 12±1.8, and 15±2.0, while nasal breathing was similar with 10±2.5, 
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12±2.2, and 15±2.3.   However, there was significant interaction between intensity and 
breathing mode in HR and RPE during 2x3 RM ANOVA factorial analysis (p<.001). 
The mean and standard deviation for the voluntary switching point of all the 
subjects was 52.5±14.2 L/min.  Switching point for the genders was 66.2±13.7 L/min for 
males and 44.9±10.5 L/min for females.    
Forced expiratory volume was statistically significant between the pre and 
posttest of the oral breathing condition (p=.003) as seen in Table 3 and Figure 7.   The 
pretest values were 3.84±.94 L for the oral breathing test and 3.98±.92 L for the nasal 
breathing test which resulted in a significant result between the two breathing modes 
(p=.032).    
 
Table 3: Forced expiratory volume comparisons 
FEV1 Pre Post 
Oral (L) 3.84±.94ab 4.04±.93a 
Nasal (L) 3.98±.92b 3.97±.90 
a: significant difference between oral pre and post tests 
b: significant difference between pretests in the two breathing modes 
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Figure 7: Forced expiratory volume comparisons 
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Chapter 5 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
Discussion 
 The study was carried out in attempt to provide evidence regarding the most 
efficient breathing mode during various submaximal intensities of exercise.  Oral 
breathing and nasal breathing both have physiological benefits and shortcomings, but the 
aim of this investigation was to conclude which mode of breathing is energetically more 
efficient.  Oral breathing is able to produce a larger volume of air due to the size of the 
passage way, whereas nasal breathing can humidify, purify, and filtrate the air allowing 
the gas to be selectively chosen to be is inspired.  Due to the unique properties and 
advantages of both breathing modes; the overall respiratory measures, ventilation, and 
oxygen consumption were greater throughout the investigation in oral breathing.   
 The greatest difference between breathing through the nose and mouth is the 
amount of air that can be transported into the lungs for respiration.  The total VE between 
the two breathing modes were significantly different between all three intensities 
(p<.001).  Nasal breathing produced lower VE which corresponds with previous reports 
by Michailow et al. (1976), and Morton et al. (1995).  The nose cannot transport the same 
volume of air as the mouth at any given exercise intensity. However it is unknown 
whether this limitation in VE be made up through other respiratory or metabolic 
measures to make nasal breathing worthy.  VE increased in both conditions as the 
exercise intensity increased.  The separation between oral VE compared to nasal VE was 
even more apparent during higher levels of exercise with a 23% decrease.  Two 
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participants dropped out of the study during the nasal breathing trial, and anecdotally the 
limited ventilation may have led to a feeling of panic feeling and termination of the test.  
Due to the nasal cavity being larger in anatomical structure, it creates greater dead 
space than oral breathing (Tanaka et al, 1988).  The greater volume of dead space creates 
a decrease in ventilation during nasal breathing.  The structure and length of the nasal 
cavity could have a small influence on the significant ventilation changes seen between 
the two breathing modes.  Besides the longer passageway, the nose has greater resistance 
to air than the mouth.  The nasal cavity is filled with fine coarse hairs and vibrissae that 
filter and trap pollutants and toxicants.  The unnecessary particles are immediately 
expired and sent back out the nasal cavity.  The extra resistance from the filtering process 
would lead to a decrease in ventilation through the nasal cavity.   
Comparing the switching point in the males was 60.2 L/min and in females was 
44.9 L/min.  The voluntary switching point was in the range stated in previous research 
(Ninimaa et al., 1980; Saibene et al., 1978) with the designated range of 35-45 L/min.  
Males generally have larger facial structures due to their larger frame, and it is likely that 
the nostrils and nasal cavity are also greater in volume than in females.  This could allow 
for males to have greater VE rates and inspiratory strength through the nasal cavity (Hall 
et al., 2006) and result in a higher switching point than females. Further investigation is 
necessary to confirm this observation. 
Another common physiological phenomenon that was observed in the present 
study was that RR was significantly lower in nasal breathing than oral breathing.   The 
mouth can easily obtain and exchange large volumes of air with short, quick breaths.  The 
nasal cavity cannot reach the same volumes of air and does not have the capabilities to 
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rapidly inspire and expire at the rate that the mouth is able to.  RR was significantly lower 
in all intensities which relates to our previously unpublished study (2014), Hall et al., 
2006, Bennet et al., 2003, and Chinevere et al., 1999,.  The last stage produced roughly 
55 br/min in oral breathing compared to 38 br/min in nasal breathing.  As more CO2 is 
being expired, the sensation to breathe is increased.  If you are unable to increase the rate 
at which are able to complete respiration, then the oxygen consumption will not meet the 
body’s needs.   
The Veq/O2 and Veq/CO2 both produced significant differences at the 65% and 
80% intensities.  During 50% of the individuals VO2 max, an exercise stage comparable 
to a brisk walk or light jog, the Veq/O2 and Veq/CO2 were similar between the breathing 
modes.  At the higher intensities, there was a significant response that nasal breathing 
was a more efficient breathing mode due to greater amounts of the O2 and CO2 being 
produced per volume of air.  Due to the lower volumes of air being created at the higher 
intensities in nasal breathing the oxygen consumption and carbon dioxide expiration was 
sufficient to complete the work rate.  When aerobically training above 50% of an 
individual’s max VO2, by this definition nasal breathing is a greater source of metabolic 
efficiency.   The work rates were attainable for 19 of the 21 individuals in the study 
presenting the belief that per volume of air being transferred, nasal breathing utilizes the 
molecules more efficiently than oral breathing. 
During the 50% work intensity, there appears to be a trend of the oxygen 
consumption to reach steady state during oral breathing as shown in Figure 8.  There is a 
noticeable difference between nasal breathing and oral breathing as the nasal breathing 
mode produced lower values at all of the time values.  At roughly the two minute mark 
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the VO2/kg value began to plateau for oral breathing but it is unclear whether the nasal 
breathing trial produced steady state values. The length of time to reach steady state 
during exercise under the condition of nasal breathing is an area that necessitates further 
investigation. 
 
Figure 8: Oxygen consumption at 50% of VO2 max 
Figure 9: Oxygen consumption at 65% of VO2 max (Left)  
Figure 10: Oxygen consumption at 80% of VO2 Max (Right)  
 
At the 65% VO2 max work intensity both breathing modes were continuously 
increasing and no distinct plateau or steady state can be clearly identified in either mode 
(see figure 9). Nasal breathing displays a greater incline of VO2/kg values as steady state 
was not reached.   As the study’s protocol moved towards 80% VO2 max the oxygen 
consumption values continued a steady incline, but never reached a constant rate (see 
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figure 10). The lack of steady state found at 80% intensity suggests that 4 minutes is not 
an appropriate length of time for a stage requiring this level of exertion.  During all 
intensities the nasal breathing mode was lower and visually shows that nasal breathing 
underperformed in terms of oxygen consumption.  There were lower oxygen 
consumption values in nasal breathing ranging from 5-14% throughout all the time points 
in the study. It is likely that oxygen consumption values are consistently lower during the 
nasal breathing trials because of insufficient time to reach steady state.  
Using the Fick equation (VO2/kg = Q x a-vO2 diff) to explain oxygen 
consumption is standard in physiology.  Cardiac output is the product of heart rate and 
stroke volume.  Stroke volume should have a similar value throughout both breathing 
modes.  As the resistance increases in nasal breathing, the blood pressure might increase 
minimally causing a small adjustment to stroke volume.   With lower HR in nasal 
breathing there may be minor compensation to increase stroke volume.  SV was not 
measured in this investigation but these possibilities seem reasonably small and should 
not influence the gross effect on cardiac output.  The heart rates between the two 
breathing modes were not statistically significant at the lowest intensities.  As the 
exercise demand increased the HR showed a 4% and 5% decrease in nasal breathing in 
the 65% and 80% relative intensities.  These findings are congruent to Morton et al. 
(1995) and Chinevere et al. (1999), that nasal breathing will produce lower HR than other 
breathing conditions involving the mouth.   During the nasal breathing protocol, lower 
heart rates transpired which infers the body was not able to reach the same physical 
working capacity.  That would lead to a theoretically lower cardiac output; however, not 
significant enough to substantially account for the 10% change in VO2.  
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The latter part of the Fick equation leads involves a-vO2 difference which 
measures the delivery of the oxygen to the muscles.  The larger the difference between 
arterial and venous oxygenated blood will potentially result in greater aerobic 
performance.  The oxygen saturation in the present study was found to be significantly 
different between oral and nasal breathing at the 80% intensity.  With a 2% change 
between oxygen saturation in the last intensity the venous oxygenated blood could be 1-2 
mmHg (based off conversion table) lower than with the oral breathing mode. Oxygen 
saturation provided no statistically significant difference during the first two intensities.  
The last stage was significant at p=.035 and was 2.2% greater in oral breathing.  Resting 
SaO2 is between 95-98% and normally does not have much variance.  To find 
statistically significant data at the highest intensity of this study provides evidence to the 
postulation by Morton et al. (1995) that slower respiration rates will results in less O2 
transported through the body.   
 
Table 4: Conversion table of oxygen saturation to arterial and mixed venous oxygenation 
content in blood 
 
 
 
 
 
 
A standard used in the exercise science field is the ACSM metabolic equation to 
measure oxygen cost during aerobic exercise.  All speeds above 3.5 mph were deemed as 
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running speeds.  The ACSM metabolic equation for running is VO2/kg = (0.2 x running 
speed) + (0.9 x running speed x grade) + 3.5.  Running speed is measured in m/min and 
grade was 0 during the entire protocol, eliminating that part of the equation.   Each 
individual’s oxygen cost was calculated and compared to the actual VO2/kg in all 
intensities during oral breathing and nasal breathing tests.  In 13 of the 57 conditions 
nasal breathing underperformed the estimated measure while oral breathing exceeded the 
value.  That leads to the possibility that anaerobic pathways made up for the deficit in 
oxygen delivery and utilization.  For the stage to be completed with less oxygen 
consumption there must be other physiological contributions for the demands to be met.  
Due to the short stages, it is likely that greater anaerobic contributions compensated for 
the reduction in oxygen.  Unfortunately, lactate measures were not obtained in the present 
study, and this is a measurement that would be warranted in future investigations on nasal 
breathing.   
The pre-test for FEV1 was significantly greater in oral breathing (p<.05).  Resting 
values should have been consistent considering the test conditions being counterbalanced 
and kept from the subjects until their first submaximal test.  Our results do not agree with 
previous investigations. There was an opposite response when compared to asthmatic 
study when breathing through the nose or keeping the mouth taped shut.  The following 
studies:  Mangla et al., 1981, Benninger et al., 1992, and Cooper et al., 2008 all found 
FEV1 values to be higher in nasal breathing conditions compared to oral breathing. 
Relaxing the thoracic muscles and diaphragm should allow the contraction and forced 
expiratory volume to be larger after undergoing exercise in the nasal breathing condition 
(Mangla et al, 1981), but those results did not occur in this study.  The short relative time 
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of exercise might have been a warm up to the thoracic muscles therefore not creating any 
fatigue in the area.  No response in FEV1 after the nasal breathing condition could be a 
result from individuals gasping for air as soon as tape was removed from their mouth.  
The goal was to test the FEV1 within 20 seconds of exercise.  There were limitations to 
not completing this sooner due to the multiple facets of the mask.  Individuals would gasp 
for air with their mouth shortly after the tape being pulled off of their mouth, possibly 
creating lower scores on the FEV1 test that occurred shortly after. 
Nasal breathing was more efficient strictly based on the variable Veq/O2.  
However when other variables are considered, oral breathing produced greater respiratory 
and metabolic effects.  Nasal breathing produced oxygen uptake values that were 
approximately 10% lower compared to oral breathing and there are a number of possible 
explanations. We propose that the greatest contributing factor is the inability to reach a 
steady state oxygen level, but also consider that increased anaerobic energy production, 
the restriction of airflow with nasal breathing, and increased oxygen extraction at the 
tissue level could also play roles.  
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Appendix A 
 
Department of Kinesiology and Nutrition Sciences 
INFORMED CONSENT FORM 
TITLE OF THE STUDY: Oral vs. Nasal Breathing in Submaximal Aerobic Exercise 
INVESTIGATOR/S: Dr. James Navalta 
CONTACT INFORMATION: If you have any questions or concerns about the study, please contact Dr. 
Navalta at (702) 895-2344.  
For questions regarding the rights of research subjects, any complaints or comments regarding the 
manner in which the study is being conducted you may contact the UNLV Office of Research Integrity – 
Human Subjects Research at (702) 895-2794. 
Purpose 
We wish to observe the respiratory responses during submaximal aerobic exercise comparing mouth to 
nose breathing. 
 
Participants 
You are being asked to participate in the study because you are between the ages of 18-44 years, and are 
a healthy, active non-smoking individual. 
 
Procedure 
If you volunteer to participate in this part of the study, you will be asked to report to the Exercise 
Physiology Laboratory on three occasions at a mutually agreed upon time. You will be screened for heart 
and lung disease using the American College of Sports Medicine’s Health-Risk Questionnaire. Your height, 
weight, and percent body fat will be measured. Your aerobic fitness (VO2 max) will be determined by 
breathing in a mask that covers your mouth and nose – you should be able to breathe normally when 
wearing this mask. This test involves walking and then running/jogging on a treadmill at progressively 
increasing speeds to exhaustion, or until a research team member stops the test due to physical 
manifestations of fatigue. Heart rate will be measured using a heart rate monitor. On the other times (one 
test nose breathing, one test mouth breathing), you will be asked to complete two submaximal treadmill 
runs for a total of 12 minutes. 
 
Risks 
This study involves some risk to you. One exercise test requires you to work at maximal abilities and is 
therefore demanding, vigorous, and stressful. The American College of Sports Medicine has stated that 
the risk of death during or immediately after a maximal exertion test is less than or equal to 0.01%, while 
the risk of an acute myocardial infarction is less than or equal to 0.04%. Data from these surveys included 
a wide variety of healthy AND diseased individuals. Since you are an apparently healthy adult between the 
ages of 18 - 44 years and are considered “low-risk” according to the American College of Sports Medicine 
guidelines, no medical supervision is necessary during the exercise test. There are discomforts to the test. 
Muscle soreness, nausea, breathlessness, dizziness, and lightheadedness may occur. There is the 
possibility of falling or tripping on the treadmill. Muscle soreness may ensue 24-48 hours later. The tests 
will be stopped any time you are not adapting well to the activity or when any major discomfort arises. 
You will be instructed to grab onto the handrails and straddle the treadmill when you wish to end the 
exercise test. In addition, a research team member will “spot” you from behind during the test.  
Benefits of Participation 
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There is no financial cost to you for participating in this study. You will be able to receive information 
regarding your cardiovascular fitness. 
 
Cost /Compensation 
There will not be any financial cost to you to participate in this study.  The study will take approximately 
three hours of your time during the laboratory visits; however there is no compensation for your time.  
 
Participation 
Your participation in this study is completely voluntary. You may refuse to participate in this study or in 
any part of this study and you may withdraw at any time without prejudice to your relations with the 
University. You are encouraged to ask questions about this study prior to the beginning or at any time 
during the study. You will be given a copy of this form. 
 
Confidentiality 
All information gathered in this study will be kept completely confidential. Only those persons who are 
directly related to this study (i.e.: researchers, data analysts) will have access to your data. No reference 
will be made in written or oral materials, which could link you to this study. All records will be stored at 
UNLV for a period of 3 years. After 3 years, any documentation with identifiable information (e.g., name) 
will be destroyed. Unidentifiable data will be stored in locked storage indefinitely. 
 
Freedom to Consent 
I have read the above information carefully and I am aware of the tests/procedures to be performed. 
Knowing these risks and having the opportunity to ask questions, I agree (consent) to participate in this 
study. With this freedom to consent, I have a right to withdraw from this study at any time without 
prejudice. I am at least 18 years old and a copy of the informed consent has been given to me. 
 
                       
Signature of the Participant   Date 
 
 
 
                       
Signature of Witness       Date 
 
 
 
 
Participant Note: Please do not sign this document if the Approval Stamp is missing or is expired. 
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Appendix B 
AHA/ACSM Health Risk Questionnaire 
Assess your health status by marking all true statements 
 
History 
You have had: 
____ a heart attack 
____ heart surgery 
____ cardiac catheterization 
____ coronary angioplasty (PTCA) 
____ pacemaker/implantable cardiac 
____ defibrillator/rhythm disturbance 
____ heart valve disease 
____ heart failure 
____ heart transplantation 
____ congenital heart disease 
 
Symptoms 
____ You experience chest discomfort with exertion 
____ You experience unreasonable breathlessness 
____ You experience dizziness, fainting, or blackouts 
____ You take heart medications 
 
Other health issues 
____ You have diabetes 
____ You have asthma or other lung disease 
____ You have burning or cramping sensation in your lower legs when walking short distances 
____ You have musculoskeletal problems that limit your physical activity 
____ You take prescription medication(s) 
____ You are pregnant 
 
 
Cardiovascular risk factors 
 
____ You smoke, or quit smoking within the previous 6 months 
____ Your blood pressure is >140/90 mm Hg 
____ You take blood pressure medication 
____ Your blood cholesterol level is >200 mg/dL 
____ You have a close blood relative who had a heart attack or heart surgery before age 55      
(father or brother) or age 65 (mother or sister) 
____ You are physically inactive (i.e., you get <30 minutes of physical activity on at least 3 days 
per week) 
____ You are > 20 pounds overweight 
________________________________________________________________ 
 
____ None of the above 
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Appendix C 
Table 3: 2x3 RM ANOVA Results - Values are presented as probabilities 
 Mauchly's Test of Sphericity Test of Within Subject Effects 
 Intensity Intensity * 
Breathing Mode 
Intensit
y 
Breathing 
Mode 
Intensity * 
Breathing Mode 
F 
HR 0.001 0.03a 0.003c 0.336 0.001e 160.1 
RR 0.115 0.039a 0.113 0.001d 0.001e 87.3 
VE 0.001 0.002a 0.036c 0.001d 0.0013 152.9 
RER 0.048 0.001a 0.012c 0.188 0.0013 82.1 
VO2/kg 0.013 0.066b 0.001c 0.022d 0.0013 232 
VO2 0.005 0.083b 0.001c 0.019d 0.0013 236.8 
VCO2 0.002 0.091b 0.001c 0.025d 0.001e 318.3 
Veq/O2 0.302 0.005a 0.001c 0.009d 0.001e 32.5 
Veq/CO2 0.618 0.01a 0.001c 0.046d 0.775 0.178 
RPE 0.063 0.002a 0.002c 0.586 0.001e 91.7 
SaO2 0.004 0.226b 0.001c 0.13 0.034e 3.7 
a: Sphericity was violated, reject the null hypothesis, and use Huyn-Feldt in Within 
Subject Effect Analysis 
b: Sphericity assumed, retain the null hypothesis, and use Sphericity Assumed in Within 
Subject Effect Analysis 
c: Main effect analysis for Intensity is significant 
d: Main effect analysis for Breathing mode is significant 
e: Interaction is significant for the 2x3 factorial ANOVA 
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Appendix D 
2x3 RM ANOVA - HR 
Descriptive Statistics 
 
Mean Std. Deviation N 
HR 131.8070 11.56587 19 
HR2 157.0877 9.70480 19 
HR3 174.5965 9.92850 19 
N_HR 131.8596 13.62791 19 
N_HR2 151.1140 16.79654 19 
N_HR3 166.2896 19.76571 19 
 
Mauchly's Test of Sphericitya 
Measure:   HR   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
Intensity .223 25.546 2 .000 .563 .574 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.663 6.991 2 .030 .748 .800 .500 
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Tests of Within-Subjects Effects 
Measure:   HR  
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
Intensity Huynh-
Feldt 
3929.870 1.148 3422.089 10.600 .003 
Error(intensity) Huynh-
Feldt 
6673.650 20.671 322.852   
breathing_mode Huynh-
Feldt 
16.469 1.000 16.469 .898 .356 
Error(breathing_mode) Huynh-
Feldt 
329.945 18.000 18.330   
intensity * breathing_mode Huynh-
Feldt 
25594.114 1.601 15989.284 160.138 .000 
Error(intensity*breathing_mode) Huynh-
Feldt 
2876.861 28.813 99.847   
 
Paired Samples t-test - HR 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 HR 131.8070 19 11.56587 2.65339 
N_HR 131.8596 19 13.62791 3.12646 
Pair 2 HR2 157.0877 19 9.70480 2.22643 
N_HR2 151.1140 19 16.79654 3.85339 
Pair 3 HR3 174.5965 19 9.92850 2.27775 
N_HR3 166.2896 19 19.76571 4.53456 
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Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
Pair 1 HR - N_HR -.05263 7.82230 1.79456 -.029 18 .977 
Pair 2 HR2 - N_HR2 5.97368 15.13706 3.47268 1.720 18 .103 
Pair 3 HR3 - N_HR3 8.30684 20.64094 4.73536 1.754 18 .096 
 
One way ANOVA – oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   HR   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .240 24.228 2 .000 .568 .581 .500 
 
Tests of Within-Subjects Effects 
Measure:   HR   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 17585.197 1.162 15132.388 198.506 .000 
Error(intensity) Huynh-Feldt 1594.581 20.918 76.231   
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Pairwise Comparisons 
Measure:   HR   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -25.281 2.138 .000 -30.923 -19.638 
3 -42.789 2.868 .000 -50.359 -35.220 
2 3 -17.509 1.091 .000 -20.388 -14.630 
 
One way ANOVA – nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   HR   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .370 16.889 2 .000 .614 .635 .500 
 
Tests of Within-Subjects Effects 
Measure:   HR   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 11314.218 1.271 8902.336 43.197 .000 
Error(intensity) Huynh-Feldt 4714.625 22.877 206.089   
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Pairwise Comparisons 
Measure:   N_HR   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -19.254 3.719 .000 -29.070 -9.439 
3 -34.430 4.820 .000 -47.152 -21.708 
2 3 -15.176 2.071 .000 -20.641 -9.710 
 
2x3 RM ANOVA - VE 
Descriptive Statistics 
 
Mean Std. Deviation N 
VE 43.4454 12.80177 19 
VE2 60.2054 13.36375 19 
VE3 76.9247 17.46169 19 
N_VE 36.1130 10.72503 19 
N_VE2 48.2148 11.04484 19 
N_VE3 59.3154 14.17530 19 
 
Mauchly's Test of Sphericitya 
Measure:   VE   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .347 18.003 2 .000 .605 .625 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.480 12.470 2 .002 .658 .689 .500 
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Tests of Within-Subjects Effects 
Measure:   VE  
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
intensity Huynh-
Feldt 
422.733 1.250 338.220 4.605 .036 
Error(intensity) Huynh-
Feldt 
1652.509 22.498 73.452   
breathing_mode Huynh-
Feldt 
531.151 1.000 531.151 28.449 .000 
Error(breathing_mode) Huynh-
Feldt 
336.064 18.000 18.670   
intensity * breathing_mode Huynh-
Feldt 
19131.194 1.379 13875.490 152.950 .000 
Error(intensity*breathing_mode) Huynh-
Feldt 
2251.469 24.818 90.719   
 
Paired samples t-test - VE 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 VE 43.4454 19 12.80177 2.93693 
N_VE 36.1130 19 10.72503 2.46049 
Pair 2 VE2 60.2054 19 13.36375 3.06586 
N_VE2 48.2148 19 11.04484 2.53386 
Pair 3 VE3 76.9247 19 17.46169 4.00599 
N_VE3 59.3154 19 14.17530 3.25204 
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Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
Pair 1 VE - N_VE 7.33246 6.76051 1.55097 4.728 18 .000 
Pair 2 VE2 - N_VE2 11.99061 8.18763 1.87837 6.384 18 .000 
Pair 3 VE3 - N_VE3 17.60930 11.59145 2.65926 6.622 18 .000 
 
One way ANOVA – oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   VE   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .327 19.024 2 .000 .598 .616 .500 
 
Tests of Within-Subjects Effects 
Measure:   VE   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 5117.537 1.613 3173.487 87.623 .000 
Error(intensity) Huynh-Feldt 1051.278 29.027 36.218   
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Pairwise Comparisons 
Measure:   VE   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -16.760 1.980 .000 -21.985 -11.535 
3 -33.479 2.740 .000 -40.712 -26.247 
2 3 -16.719 1.202 .000 -19.892 -13.547 
 
One way ANOVA – nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_VE   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
Intensity .671 6.775 2 .034 .753 .806 .500 
 
Tests of Between-Subjects Effects 
Measure:   N_VE 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 130678.086 1 130678.086 344.298 .000 
Error 6831.893 18 379.550   
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Pairwise Comparisons: N_Ve 
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
1 2 -12.102 1.518 .000 
3 -23.202 2.198 .000 
2 3 -11.101 1.444 .000 
 
2x3 RM ANOVA – RR 
Mauchly's Test of Sphericitya 
Measure:   RR   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .776 4.307 2 .116 .817 .888 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.683 6.471 2 .039 .760 .815 .500 
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Tests of Within-Subjects Effects 
Measure:   RR 
Source 
Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
intensity Huynh-Feldt 108.075 1.775 60.883 2.390 .113 
Error(intensity) Huynh-Feldt 813.908 31.952 25.473   
breathing_mode Huynh-Feldt 421.351 1.000 421.351 30.918 .000 
Error(breathing_mode) Huynh-Feldt 245.302 18.000 13.628   
intensity * breathing_mode Huynh-Feldt 6517.855 1.630 3998.859 87.307 .000 
Error(intensity*breathing_mode) Huynh-Feldt 1343.782 29.339 45.802   
 
Paired Samples t-test – RR 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 RR 33.3333 19 8.06532 1.85031 
N_RR 25.2809 19 7.01657 1.60971 
Pair 2 RR2 41.0000 19 9.43136 2.16370 
N_RR2 32.5528 19 7.31146 1.67736 
Pair 3 RR3 50.4912 19 10.94113 2.51007 
N_RR3 38.5614 19 7.32158 1.67969 
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Paired Samples Test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 
1 
RR - 
N_RR 
8.05246 6.19670 1.42162 5.664 18 .000 
Pair 
2 
RR2 - 
N_RR2 
8.44719 6.51076 1.49367 5.655 18 .000 
Pair 
3 
RR3 - 
N_RR3 
11.92982 7.65747 1.75674 6.791 18 .000 
 
One way ANOVA - oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   RR 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .714 5.732 2 .057 .777 .837 .500 
 
Tests of Within-Subjects Effects 
Measure:   RR   
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
intensity Sphericity Assumed 2807.279 2 1403.639 55.999 .000 
Error(intensity) Sphericity Assumed 902.351 36 25.065   
 
  
  
73
Pairwise Comparisons 
Measure:   RR   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig. 
1 2 -7.667 1.701 .001 
3 -17.158 1.927 .000 
2 3 -9.491 1.144 .000 
 
One way ANOVA - nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_RR 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .864 2.492 2 .288 .880 .968 .500 
 
Tests of Within-Subjects Effects 
Measure:   N_RR   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Sphericity Assumed 1680.592 2 840.296 44.095 .000 
Error(intensity) Sphericity Assumed 686.026 36 19.056   
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Pairwise Comparisons 
Measure:   N_RR   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
1 2 -7.272 1.322 .000 
3 -13.281 1.654 .000 
2 3 -6.009 1.239 .000 
 
2x3 RM ANOVA - RER 
Descriptive Statistics 
 
Mean Std. Deviation N 
RER .8470 .06138 19 
RER2 .9246 .04308 19 
RER3 .9786 .04098 19 
N_RER .8037 .08383 19 
N_RER2 .8776 .06617 19 
N_RER3 .9475 .07529 19 
 
Mauchly's Test of Sphericitya 
Measure:   RER 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .699 6.091 2 .048 .769 .826 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.287 21.225 2 .000 .584 .600 .500 
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Tests of Within-Subjects Effects 
Measure:   RER 
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
intensity Huynh-
Feldt 
.015 1.653 .009 5.594 .012 
Error(intensity) Huynh-
Feldt 
.049 29.745 .002   
breathing_mode Huynh-
Feldt 
.002 1.000 .002 1.874 .188 
Error(breathing_mode) Huynh-
Feldt 
.023 18.000 .001   
intensity * breathing_mode Huynh-
Feldt 
.392 1.199 .327 82.129 .000 
Error(intensity*breathing_mode) Huynh-
Feldt 
.086 21.582 .004   
 
Paired Samples t-test - RER 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 RER .8470 19 .06138 .01408 
N_RER .8037 19 .08383 .01923 
Pair 2 RER2 .9246 19 .04308 .00988 
N_RER2 .8776 19 .06617 .01518 
Pair 3 RER3 .9786 19 .04098 .00940 
N_RER3 .9475 19 .07529 .01727 
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Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
Pair 1 RER - N_RER .04333 .05588 .01282 3.380 18 .003 
Pair 2 RER2 - N_RER2 .04693 .05271 .01209 3.881 18 .001 
Pair 3 RER3 - N_RER3 .03105 .06663 .01529 2.031 18 .057 
 
One way ANOVA – oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   RER 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .406 15.311 2 .000 .627 .652 .500 
 
Tests of Within-Subjects Effects 
Measure:   RER 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt .166 1.305 .127 75.943 .000 
Error(intensity) Huynh-Feldt .039 23.481 .002   
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Pairwise Comparisons 
Measure:   RER   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -.078 .010 .000 -.105 -.050 
3 -.132 .014 .000 -.169 -.095 
2 3 -.054 .007 .000 -.071 -.037 
 
One way ANOVA – nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_RER   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .861 2.538 2 .281 .878 .966 .500 
 
Tests of Within-Subjects Effects 
Measure:  N_ RER 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
intensity Sphericity Assumed .197 2 .098 73.321 .000 
Error(intensity) Sphericity Assumed .048 36 .001   
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Pairwise Comparisons 
Measure:   N_RER   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -.074 .011 .000 -.102 -.046 
3 -.144 .014 .000 -.181 -.107 
2 3 -.070 .011 .000 -.099 -.041 
 
2x3 RM ANOVA - RPE 
Descriptive Statistics 
 
Mean Std. Deviation N 
RPE 9.1754 1.72623 19 
RPE2 12.0702 1.79361 19 
RPE3 15.2018 1.96307 19 
N_RPE 9.5261 2.45548 19 
N_RPE2 12.3247 2.20148 19 
N_RPE3 15.4475 2.30260 19 
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Mauchly's Test of Sphericitya 
Measure:   RPE  
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .722 5.544 2 .063 .782 .844 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.485 12.294 2 .002 .660 .692 .500 
 
Tests of Within-Subjects Effects 
Measure:   RPE   
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
Intensity Huynh-
Feldt 
202.641 1.687 120.117 37.286 .000 
Error(intensity) Huynh-
Feldt 
97.826 30.367 3.222   
breathing_mode Huynh-
Feldt 
.370 1.000 .370 .308 .586 
Error(breathing_mode) Huynh-
Feldt 
21.613 18.000 1.201   
intensity * breathing_mode Huynh-
Feldt 
477.898 1.384 345.281 91.648 .000 
Error(intensity*breathing_mode) Huynh-
Feldt 
93.861 24.913 3.767   
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Paired Samples t-test - RPE 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 RPE 9.1754 19 1.72623 .39602 
N_RPE 9.5261 19 2.45548 .56333 
Pair 2 RPE2 12.0702 19 1.79361 .41148 
N_RPE2 12.3247 19 2.20148 .50505 
Pair 3 RPE3 15.2018 19 1.96307 .45036 
N_RPE3 15.4475 19 2.30260 .52825 
 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
Pair 1 RPE - N_RPE -.35070 2.73215 .62680 -.560 18 .583 
Pair 2 RPE2 - N_RPE2 -.25456 1.62539 .37289 -.683 18 .504 
Pair 3 RPE3 - N_RPE3 -.24579 1.58100 .36271 -.678 18 .507 
 
One way ANOVA – oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   RPE   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. Chi-
Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
Intensity .691 6.285 2 .043 .764 .820 .500 
  
  
81
Tests of Within-Subjects Effects 
Measure:   RPE   
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Intensity Huynh-Feldt 345.184 1.641 210.370 123.034 .000 
Error(intensity) Huynh-Feldt 50.501 29.535 1.710   
 
Pairwise Comparisons 
Measure:   RPE   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -2.895 .365 .000 -3.858 -1.931 
3 -6.026 .474 .000 -7.278 -4.775 
2 3 -3.132 .291 .000 -3.901 -2.363 
 
One way ANOVA – nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_RPE 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .414 14.996 2 .001 .630 .656 .500 
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Tests of Within-Subjects Effects 
Measure:   N_RPE   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 333.432 1.312 254.181 75.954 .000 
Error(intensity) Huynh-Feldt 79.019 23.612 3.347   
 
Pairwise Comparisons 
Measure:   N_RPE 
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -2.799 .437 .000 -3.951 -1.646 
3 -5.921 .633 .000 -7.591 -4.252 
2 3 -3.123 .319 .000 -3.966 -2.280 
 
2x3 RM ANOVA – SaO2 
Descriptive Statistics 
 
Mean Std. Deviation N 
SaO2 95.8947 1.57939 19 
SaO22 94.2281 2.80443 19 
SaO23 93.3333 2.56520 19 
N_SaO2 94.6756 4.10307 19 
N_SaO22 92.6314 4.47778 19 
N_SaO23 91.2191 3.59078 19 
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Mauchly's Test of Sphericitya 
Measure:   SaO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .520 11.105 2 .004 .676 .711 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.840 2.972 2 .226 .862 .945 .500 
 
Tests of Within-Subjects Effects 
Measure:   SaO2 
Source 
Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
intensity Sphericity 
Assumed 
193.491 2 96.745 10.268 .000 
Error(intensity) Sphericity 
Assumed 
339.204 36 9.422   
breathing_mode Sphericity 
Assumed 
9.551 1 9.551 2.523 .130 
Error(breathing_mode) Sphericity 
Assumed 
68.143 18 3.786   
intensity * breathing_mode Sphericity 
Assumed 
52.903 2 26.451 3.730 .034 
Error(intensity*breathing_mode) Sphericity 
Assumed 
255.274 36 7.091   
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Paired Samples t-test – SaO2 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 SaO2 95.8947 19 1.57939 .36234 
N_SaO2 94.6756 19 4.10307 .94131 
Pair 2 SaO22 94.2281 19 2.80443 .64338 
N_SaO22 92.6314 19 4.47778 1.02727 
Pair 3 SaO23 93.3333 19 2.56520 .58850 
N_SaO23 91.2191 19 3.59078 .82378 
 
Paired Samples Test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 SaO2 - N_SaO2 1.21912 4.30700 .98809 1.234 18 .233 
Pair 2 SaO22 - 
N_SaO22 
1.59667 4.90925 1.12626 1.418 18 .173 
Pair 3 SaO23 - 
N_SaO23 
2.11421 4.04127 .92713 2.280 18 .035 
 
One way ANOVA – oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   SaO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
Intensity .958 .738 2 .692 .959 1.000 .500 
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Tests of Within-Subjects Effects 
Measure:   SaO2 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
intensity Sphericity Assumed 64.214 2 32.107 14.831 .000 
Error(intensity) Sphericity Assumed 77.934 36 2.165   
 
Pairwise Comparisons 
Measure:   SaO2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 1.667 .475 .008 .414 2.920 
3 2.561 .519 .000 1.191 3.932 
2 3 .895 .434 .162 -.251 2.040 
 
One way ANOVA – nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_SaO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square Df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .949 .897 2 .639 .951 1.000 .500 
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Tests of Within-Subjects Effects 
Measure:   N_SaO2 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Intensity Sphericity Assumed 114.764 2 57.382 12.775 .000 
Error(intensity) Sphericity Assumed 161.706 36 4.492   
 
Pairwise Comparisons 
Measure:   N_ SaO2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 2.044 .746 .040 .075 4.013 
3 3.456 .611 .000 1.845 5.068 
2 3 1.412 .699 .176 -.433 3.258 
 
2x3 RM ANOVA – VO2/kg  
Descriptive Statistics 
 
Mean Std. Deviation N 
VO2_KG 29.7439 6.58121 19 
VO2_KG2 38.3351 3.97255 19 
VO2_KG3 44.4667 4.00077 19 
N_VO2_KG 26.7586 5.98361 19 
N_VO2_KG2 34.9309 3.74222 19 
N_VO2_KG3 40.9439 4.92262 19 
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Mauchly's Test of Sphericitya 
Measure:   VO2/kg 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .602 8.627 2 .013 .715 .760 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.726 5.444 2 .066 .785 .847 .500 
 
Tests of Within-Subjects Effects 
Measure:   VO2/kg 
Source 
Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
intensity Sphericity 
Assumed 
292.256 2 146.128 9.810 .000 
Error(intensity) Sphericity 
Assumed 
536.249 36 14.896   
breathing_mode Sphericity 
Assumed 
30.507 1 30.507 6.299 .022 
Error(breathing_mode) Sphericity 
Assumed 
87.183 18 4.844   
intensity * breathing_mode Sphericity 
Assumed 
3993.131 2 1996.566 231.947 .000 
Error(intensity*breathing_mode) Sphericity 
Assumed 
309.883 36 8.608   
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Paired Samples t-test – VO2/kg 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 VO2_KG 29.7439 19 6.58121 1.50983 
N_VO2_KG 26.7586 19 5.98361 1.37273 
Pair 2 VO2_KG2 38.3351 19 3.97255 .91137 
N_VO2_KG2 34.9309 19 3.74222 .85853 
Pair 3 VO2_KG3 44.4667 19 4.00077 .91784 
N_VO2_KG3 40.9439 19 4.92262 1.12933 
 
Paired Samples Test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 VO2_KG - 
N_VO2_KG 
2.98526 4.74674 1.08898 2.741 18 .013 
Pair 2 VO2_KG2 - 
N_VO2_KG2 
3.40421 4.19339 .96203 3.539 18 .002 
Pair 3 VO2_KG3 - 
N_VO2_KG3 
3.52281 4.75610 1.09112 3.229 18 .005 
 
One way ANOVA - oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   VO2/kg   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .316 19.608 2 .000 .594 .611 .500 
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Tests of Within-Subjects Effects 
Measure:   VO2/kg 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 2078.388 1.223 1699.623 187.701 .000 
Error(intensity) Huynh-Feldt 199.311 22.011 9.055   
 
Pairwise Comparisons 
Measure:   VO2/kg   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -8.591 .851 .000 -10.838 -6.344 
3 -14.723 .954 .000 -17.241 -12.204 
2 3 -6.132 .336 .000 -7.018 -5.246 
 
One way ANOVA – nasal breathing between different intensities  
Mauchly's Test of Sphericitya 
Measure:   N_VO2/kg   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .699 6.096 2 .047 .768 .826 .500 
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Tests of Within-Subjects Effects 
Measure:   N_VO2/kg   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 1926.371 1.652 1165.949 105.447 .000 
Error(intensity) Huynh-Feldt 328.834 29.739 11.057   
 
Pairwise Comparisons 
Measure:   N_VO2/kg   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -8.172 .978 .000 -10.752 -5.592 
3 -14.185 1.192 .000 -17.332 -11.039 
2 3 -6.013 .712 .000 -7.893 -4.133 
 
 
2x3 RM ANOVA – VO2 
Descriptive Statistics 
 
Mean Std. Deviation N 
VO2 2250.0877 603.70203 19 
VO22 2900.3860 533.62925 19 
VO23 3371.2807 627.06232 19 
N_VO2 2050.8333 632.23309 19 
N_VO22 2657.3247 583.51173 19 
N_VO23 3114.3507 704.07958 19 
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Mauchly's Test of Sphericitya 
Measure:   VO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .538 10.542 2 .005 .684 .721 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.746 4.990 2 .083 .797 .862 .500 
 
Tests of Within-Subjects Effects 
Measure:   VO2 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
intensity Sphericity 
Assumed 
1842598.703 2 921299.351 11.797 .000 
Error(intensity) Sphericity 
Assumed 
2811531.732 36 78098.104   
breathing_mode Sphericity 
Assumed 
143834.688 1 143834.688 6.687 .019 
Error(breathing_mode) Sphericity 
Assumed 
387154.252 18 21508.570   
intensity * breathing_mode Sphericity 
Assumed 
22421912.349 2 11210956.174 236.837 .000 
Error(intensity*breathing_mode) Sphericity 
Assumed 
1704099.758 36 47336.104   
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Paired Samples t-test – VO2 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 VO2 2250.0877 19 603.70203 138.49875 
N_VO2 2050.8333 19 632.23309 145.04422 
Pair 2 VO22 2900.3860 19 533.62925 122.42295 
N_VO22 2657.3247 19 583.51173 133.86677 
Pair 3 VO23 3371.2807 19 627.06232 143.85796 
N_VO23 3114.3507 19 704.07958 161.52693 
 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 VO2 - N_VO2 199.25439 291.41230 66.85457 2.980 18 .008 
Pair 2 VO22 - 
N_VO22 
243.06123 270.93844 62.15754 3.910 18 .001 
Pair 3 VO23 - 
N_VO23 
256.93000 337.18871 77.35640 3.321 18 .004 
 
One way ANOVA - oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   VO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .357 17.522 2 .000 .609 .629 .500 
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Tests of Within-Subjects Effects 
Measure:   VO2 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 12044121.312 1.259 9568518.160 161.223 .000 
Error(intensity) Huynh-Feldt 1344682.316 22.657 59349.457   
 
Pairwise Comparisons 
Measure:   VO2 
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -650.298 64.433 .000 -820.347 -480.249 
3 -1121.193 80.909 .000 -1334.722 -907.664 
2 3 -470.895 33.130 .000 -558.330 -383.459 
 
One way ANOVA - nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_VO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .669 6.845 2 .033 .751 .804 .500 
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Tests of Within-Subjects Effects 
Measure:   N_VO2 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 10815900.403 1.609 6723230.948 101.616 .000 
Error(intensity) Huynh-Feldt 1915907.173 28.957 66163.323   
 
Pairwise Comparisons 
Measure:   N_VO2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -606.491 70.044 .000 -791.347 -421.636 
3 -1063.517 93.152 .000 -1309.359 -817.676 
2 3 -457.026 56.770 .000 -606.850 -307.202 
 
2x3 RM ANOVA – VCO2  
Descriptive Statistics 
 
Mean Std. Deviation N 
VCO2 1923.6842 573.81397 19 
VCO22 2684.2281 524.46488 19 
VCO23 3295.8947 613.66187 19 
N_VCO2 1676.5439 612.61287 19 
N_VCO22 2353.6577 628.91814 19 
N_VCO23 2979.0788 814.35770 19 
 
  
  
95
Mauchly's Test of Sphericitya 
Measure:   VCO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .477 12.591 2 .002 .657 .688 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.755 4.785 2 .091 .803 .870 .500 
 
Tests of Within-Subjects Effects 
Measure:   VCO2  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
intensity Sphericity 
Assumed 
2495536.455 2 1247768.228 13.132 .000 
Error(intensity) Sphericity 
Assumed 
3420531.104 36 95014.753   
breathing_mode Sphericity 
Assumed 
172485.194 1 172485.194 5.944 .025 
Error(breathing_mode) Sphericity 
Assumed 
522330.010 18 29018.334   
intensity * breathing_mode Sphericity 
Assumed 
33950334.140 2 16975167.070 318.333 .000 
Error(intensity*breathing_mode) Sphericity 
Assumed 
1919707.714 36 53325.214   
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Paired Samples t-test – VCO2  
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 VCO2 1923.6842 19 573.81397 131.64195 
N_VCO2 1676.5439 19 612.61287 140.54303 
Pair 2 VCO22 2684.2281 19 524.46488 120.32049 
N_VCO22 2353.6577 19 628.91814 144.28372 
Pair 3 VCO23 3295.8947 19 613.66187 140.78369 
N_VCO23 2979.0788 19 814.35770 186.82647 
 
Paired Samples Test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 VCO2 - N_VCO2 247.14035 275.96391 63.31046 3.904 18 .001 
Pair 2 VCO22 - 
N_VCO22 
330.57035 303.56977 69.64368 4.747 18 .000 
Pair 3 VCO23 - 
N_VCO23 
316.81597 433.81912 99.52493 3.183 18 .005 
 
One way ANOVA - oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   VCO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .514 11.325 2 .003 .673 .708 .500 
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Tests of Within-Subjects Effects 
Measure:   VCO2 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 17958323.747 1.415 12691358.380 257.077 .000 
Error(intensity) Huynh-Feldt 1257402.994 25.470 49367.859   
 
Pairwise Comparisons 
Measure:   VCO2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -760.544 58.868 .000 -915.905 -605.183 
3 -1372.211 77.428 .000 -1576.555 -1167.866 
2 3 -611.667 39.614 .000 -716.213 -507.120 
 
One way ANOVA - nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_VCO2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .569 9.585 2 .008 .699 .740 .500 
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Tests of Within-Subjects Effects 
Measure:   N_VCO2 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 16126135.176 1.479 10903245.223 118.400 .000 
Error(intensity) Huynh-Feldt 2451616.297 26.622 92088.517   
 
Pairwise Comparisons 
Measure:   N_ VCO2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -677.114 71.580 .000 -866.025 -488.203 
3 -1302.535 108.911 .000 -1589.966 -1015.103 
2 3 -625.421 67.232 .000 -802.855 -447.987 
 
2x3 RM ANOVA – Veq/O2 
Descriptive Statistics 
 
Mean Std. Deviation N 
VEQO2 19.2614 1.87489 19 
VEQO22 20.7614 2.51654 19 
VEQO23 22.8596 3.16125 19 
N_VEQO2 17.9554 2.80141 19 
N_VEQO22 18.1674 1.77765 19 
N_VEQO23 19.1018 2.29165 19 
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Mauchly's Test of Sphericitya 
Measure:   Veq/O2   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .869 2.394 2 .302 .884 .973 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.531 10.758 2 .005 .681 .717 .500 
 
Tests of Within-Subjects Effects 
Measure:   Veq/O2 
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
intensity Huynh-
Feldt 
65.817 1.946 33.821 9.772 .000 
Error(intensity) Huynh-
Feldt 
121.232 35.029 3.461   
breathing_mode Huynh-
Feldt 
19.317 1.000 19.317 8.514 .009 
Error(breathing_mode) Huynh-
Feldt 
40.837 18.000 2.269   
intensity * breathing_mode Huynh-
Feldt 
238.840 1.435 166.485 32.522 .000 
Error(intensity*breathing_mode) Huynh-
Feldt 
132.189 25.823 5.119   
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Paired Samples t-test – Veq/O2 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 VEQO2 19.2614 19 1.87489 .43013 
N_VEQO2 17.9554 19 2.80141 .64269 
Pair 2 VEQO22 20.7614 19 2.51654 .57733 
N_VEQO22 18.1674 19 1.77765 .40782 
Pair 3 VEQO23 22.8596 19 3.16125 .72524 
N_VEQO23 19.1018 19 2.29165 .52574 
 
Paired Samples Test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 VEQO2 - N_VEQO2 1.30596 3.25195 .74605 1.751 18 .097 
Pair 2 VEQO22 - 
N_VEQO22 
2.59404 2.11468 .48514 5.347 18 .000 
Pair 3 VEQO23 - 
N_VEQO23 
3.75789 2.62981 .60332 6.229 18 .000 
 
One way ANOVA - oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   Veq/O2 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .291 20.987 2 .000 .585 .601 .500 
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Tests of Within-Subjects Effects 
Measure:   Veq/O2 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
intensity Huynh-Feldt 124.133 1.202 103.244 28.985 .000 
Error(intensity) Huynh-Feldt 77.088 21.642 3.562   
 
Pairwise Comparisons 
Measure:   Veq/O2 
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -1.500 .457 .012 -2.705 -.295 
3 -3.598 .630 .000 -5.262 -1.934 
2 3 -2.098 .265 .000 -2.797 -1.400 
 
One way ANOVA - nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   N_ Veq/O2   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .892 1.948 2 .378 .902 .997 .500 
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Tests of Within-Subjects Effects 
Measure:   N_ Veq/O2   
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
intensity Sphericity Assumed 14.136 2 7.068 3.289 .049 
Error(intensity) Sphericity Assumed 77.371 36 2.149   
 
Pairwise Comparisons 
Measure:   N_ Veq/O2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 -.212 .498 1.000 -1.526 1.103 
3 -1.146 .526 .129 -2.535 .243 
2 3 -.934 .392 .085 -1.969 .100 
 
2x3 RM ANOVA – Veq/CO2 
Descriptive Statistics 
 
Mean Std. Deviation N 
VEQCO2 22.8474 2.66327 19 
VEQCO22 22.5281 3.06520 19 
VEQCO23 23.4053 3.39323 19 
N_VEQCO2 22.5068 3.90704 19 
N_VEQCO22 20.7895 2.27626 19 
N_VEQCO23 20.2546 2.55796 19 
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Mauchly's Test of Sphericitya 
Measure:   Veq/CO2   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
intensity .945 .963 2 .618 .948 1.000 .500 
breathing_mode 1.000 .000 0 . 1.000 1.000 1.000 
intensity * 
breathing_mode 
.584 9.142 2 .010 .706 .749 .500 
 
Tests of Within-Subjects Effects 
Measure:   Veq/CO2   
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
Intensity Huynh-Feldt 135.366 2.000 67.683 15.830 .000 
Error(intensity) Huynh-Feldt 153.922 36.000 4.276   
breathing_mode Huynh-Feldt 9.727 1.000 9.727 4.572 .046 
Error(breathing_mode) Huynh-Feldt 38.300 18.000 2.128   
Lower-
bound 
38.300 18.000 2.128   
intensity * breathing_mode Huynh-Feldt 1.628 1.497 1.087 .178 .775 
Error(intensity*breathing_mode) Huynh-Feldt 164.682 26.952 6.110   
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Paired Samples t-test - Veq/CO2 
 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 VEQCO2 22.8474 19 2.66327 .61100 
N_VEQCO2 22.5068 19 3.90704 .89634 
Pair 2 VEQCO22 22.5281 19 3.06520 .70321 
N_VEQCO22 20.7895 19 2.27626 .52221 
Pair 3 VEQCO23 23.4053 19 3.39323 .77846 
N_VEQCO23 20.2546 19 2.55796 .58684 
 
Paired Samples Test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 VEQCO2 - 
N_VEQCO2 
.34053 3.72020 .85347 .399 18 .695 
Pair 2 VEQCO22 - 
N_VEQCO22 
1.73860 2.34142 .53716 3.237 18 .005 
Pair 3 VEQCO23 - 
N_VEQCO23 
3.15070 3.01627 .69198 4.553 18 .000 
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One way ANOVA – oral breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:   Veq/CO2   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
Intensity .437 14.070 2 .001 .640 .667 .500 
 
Tests of Within-Subjects Effects 
Measure:   Veq/CO2   
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Intensity Huynh-Feldt 7.490 1.335 5.613 2.308 .136 
Error(intensity) Huynh-Feldt 58.416 24.021 2.432   
 
Pairwise Comparisons 
Measure:   Veq/CO2   
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 .319 .372 1.000 -.663 1.301 
3 -.558 .543 .952 -1.990 .874 
2 3 -.877 .282 .018 -1.622 -.133 
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One way ANOVA - nasal breathing between different intensities 
Mauchly's Test of Sphericitya 
Measure:  N_Veq/CO2   
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
Intensity .653 7.247 2 .027 .742 .793 .500 
 
Tests of Within-Subjects Effects 
Measure:   N_Veq/CO2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intensity Huynh-Feldt 52.619 1.587 33.156 7.991 .003 
Error(intensity) Huynh-Feldt 118.529 28.566 4.149   
 
Pairwise Comparisons 
Measure:   N_VEQCO2 
(I) intensity (J) intensity 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 1.717 .594 .029 .151 3.284 
3 2.252 .721 .018 .348 4.156 
2 3 .535 .409 .621 -.543 1.613 
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Paired Samples t-test - FEV 
Paired Samples Statistics 
 
Mean N Std. Deviation Std. Error Mean 
Pair 1 FEV1 3.8426 19 .93716 .21500 
FEV12 4.0405 19 .93121 .21364 
Pair 2 N_FEV1 3.9811 19 .92176 .21147 
N_FEV2 3.9742 19 .89874 .20619 
 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 FEV1 - FEV12 -.19789 .24809 .05692 -3.477 18 .003 
Pair 2 N_FEV1 - 
N_FEV2 
.00684 .23173 .05316 .129 18 .899 
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Appendix E 
Metabolic Equation for Oxygen Cost w/ running speed  
Running - VO2/kg = (0.2 x running speed) + (0.9 x running speed x grade) + 3.5 
Walking - VO2/kg = (0.1 x walking speed) + (1.8 x running speed x grade) + 3.5 
 
Gold highlights – Oxygen Cost was met in oral breathing mode but was insufficient in 
nasal breathing 
Gray highlights – treadmill speed determined the use of walking equation 
 
 
  
oral nasal oral nasal oral nasal
50% 50% 65% 65% 80% 80%
max max o2 costrun speed max max o2 costrun speed max max o2 costrun speed
101 34.2 34.8 25.48 4.1 40.9 43.1 33.52 5.6 46.7 48.1 41.02 7
102 38.1 37.6 29.23 4.8 42.2 42.5 32.98 5.5 46.9 47.4 36.73 6.2
103 31.8 26.1 30.84 5.1 37 37.4 34.05 5.7 41 41.1 37.8 6.4
104 34.3 29.4 31.37 5.2 40.5 33.1 36.2 6.1 45.4 36.1 40.48 6.9
105 31.4 31.6 30.3 5 40.3 39.1 38.34 6.5 49.9 45.8 45.84 7.9
106 26.8 26.9 27.08 4.4 38.9 34.9 33.52 5.6 44.6 32.5 41.02 7
107 27.3 26.4 24.94 4 41.6 29.4 31.91 5.3 47.4 41.1 38.88 6.6
109 23.3 15 12.88 3.5 22.26 35.7 30.4 28.69 4.7 39.3 35.8 35.12 5.9
110 42.3 29 26.55 4.3 48.7 35.7 33.52 5.6 53.3 51.3 39.95 6.8
113 25.6 23.7 25.48 4.1 38.3 36.8 33.52 5.6 46.2 44.9 41.02 7
114 15.1 20.5 12.08 3.2 20.65 32.5 33.5 27.62 4.5 37.9 43.4 35.12 5.9
116 33.6 32.1 29.76 4.9 39.2 36.5 34.59 5.8 44.8 41.3 39.41 6.7
117 30.3 30.6 30.3 5 38.7 39.8 37.8 6.4 46.4 46 45.31 7.8
119 37.9 26.7 30.84 5.1 43.1 35.5 37.27 6.3 49.8 38.8 43.7 7.5
120 36 35.6 31.91 5.3 40.8 34.2 38.34 6.5 47.1 47.3 44.77 7.7
121 26.2 24.2 26.55 4.3 37.9 37.2 35.66 6 43.1 45.7 44.24 7.6
123 34.1 31.1 27.62 4.5 41.7 40.8 34.05 5.7 49.9 47.5 39.41 6.7
124 37.5 34.2 32.44 5.4 43.9 42.4 39.95 6.8 52 48.2 47.45 8.2
125 27.3 27.3 27.08 4.4 32.9 34.3 35.12 5.9 39.7 40.4 43.16 7.4
  
109
Appendix F 
Oral Breathing Individual Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
RR VE VO2 VCO2 RER HR VEQO2 VEQCO2 VO2_KG RPE SaO2 FEV1
1 45 49.53 2399.33 1836 0.76 148 20.63 27 33.23 9 96 3.53
2 30 52.88 2860.67 2311.33 0.81 133.33 18.47 22.83 36.27 9 96 3.49
3 42.33 38.83 1784 1487.67 0.83 141.33 21.77 26.1 30.5 7.67 96.33 2.79
4 49.67 67.44 2955.67 2648 0.89 136.67 22.8 25.43 33.77 12.33 95 3.8
5 36 50.76 2621.67 2202 0.84 118 19.4 23.07 30.73 7 98 5.37
6 35.67 41.6 1950 1555.67 0.8 130 21.3 26.8 25.6 10 98.33 4.17
7 28 30.05 1624 1325 0.82 110.67 18.47 22.63 25.2 9.33 95.67 2.06
8 26.33 25.57 1397 1081 0.78 121.67 18.3 23.67 22.47 9 97.33 2.81
9 23 35.15 2349.33 1886.67 0.8 134.67 14.97 18.67 41.4 11.33 92.33 3.25
10 34 35.62 1652.33 1456.33 0.88 127.67 21.57 24.47 23.8 7 97.67 4.39
11 26 18.11 964.67 697.67 0.72 130.67 18.77 25.97 12.73 10.33 97 2.82
12 47 64.86 3393.67 2869 0.84 133.67 19.1 22.6 32.27 11.33 94 4.45
13 26.67 41.15 2209.67 2111.33 0.95 109.33 18.6 19.47 29.37 8.33 93.33 5.09
14 29.33 37.06 2079 1777.67 0.86 136.33 17.8 20.83 36.7 8 95.33 3.7
15 34 49.2 2436.67 2083.33 0.86 158 20.17 23.63 33.8 12.33 95.67 4.6
16 20.33 40.56 2278 2036.33 0.89 132.67 17.8 19.97 25 9.33 97.33 5.61
17 35.67 58.27 2849 2675.67 0.94 138.33 20.43 21.77 32.9 7.33 95.67 4.2
18 32.33 52.53 2827 2626.67 0.93 132 18.57 19.93 34.8 7 96.33 3.47
19 32 36.3 2120 1882.67 0.89 131.33 17.07 19.27 24.6 8.67 94.67 3.41
RR2 VE2 VO22 VCO22 RER2 HR2 VEQO22 VEQCO22 VO2_KG2 RPE2 SaO22
1 54.67 63 2812.67 2427.67 0.86 164.33 22.43 25.97 38.97 13 94
2 35 64 3228 2877.67 0.89 142.33 19.8 22.23 40.9 12 94.33
3 51.67 46.13 2027.67 1779.33 0.88 158.33 22.7 25.9 34.63 9 96
4 56.67 91.72 3483.67 3354.67 0.96 160.33 26.33 27.33 39.8 13.67 90.33
5 34 64.79 3360.33 2977.67 0.88 140.33 19.27 21.77 39.4 13 96.33
6 35.33 57.59 2731.67 2322.67 0.85 160.33 21.07 24.8 35.83 12 98.33
7 37 47.91 2489.33 2301.33 0.92 152 19.2 20.8 38.63 11 92
8 44.67 46.54 2154.67 2095.33 0.97 166.33 21.57 22.13 34.67 14 95.33
9 27.67 44.8 2747.67 2582.33 0.94 151.33 16.33 17.37 48.47 13.67 87.67
10 35.67 49.63 2533.67 2368.33 0.93 156 19.53 20.93 36.5 7.33 95.33
11 58 64.33 2412.33 2147.33 0.89 167 26.67 29.97 31.8 13 94.33
12 53.67 82.88 4077 3644.67 0.89 157 20.33 22.77 38.77 12.33 89
13 30.33 54.77 2832 2795 0.99 134 19.33 19.57 37.63 12 96.67
14 37 44.89 2360 2186.67 0.93 161.67 19.03 20.53 41.6 12 93.33
15 38.67 58.18 2872 2561.67 0.89 168.67 20.23 22.7 39.83 14.33 95
16 32 62.34 3214 3059.67 0.95 160.33 19.37 20.37 35.23 12.67 97
17 42.33 79.45 3535.33 3499.67 0.99 170 22.47 22.7 40.83 13.33 93.33
18 35.33 67.96 3485 3367.33 0.97 159.67 19.5 20.2 42.93 9.67 97
19 39.33 53.01 2750.33 2651.33 0.96 154.67 19.3 20 31.93 11.33 95
RR3 VE3 VO23 VCO23 RER3 HR3 VEQO23 VEQCO23 VO2_KG3 RPE3 SaO23 FEV12
1 57.33 83.08 3340.33 3148.67 0.94 176.33 24.87 26.37 46.27 16 93 3.59
2 42.67 75 3622.67 3380.67 0.93 154.67 20.73 22.2 45.9 13 92.33 3.75
3 53.67 54.04 2320 2058.33 0.89 172.33 23.27 26.23 39.67 11.67 95 2.83
4 74 114.6 3878.33 3802.67 0.98 175 29.53 30.13 44.3 17.67 93 4.45
5 48 86.14 4074 3893 0.95 158.67 21.17 22.1 47.77 18 97 5.65
6 44.67 71.92 3326.67 3170 0.95 178.67 21.6 22.67 43.63 13.67 98.33 4.08
7 52 61.25 2882 2768.67 0.97 177.67 21.3 22.17 44.73 13.67 90 2.81
8 54 64.23 2431.33 2550 1.05 187.33 26.4 25.17 39.13 18.67 94.33 2.94
9 33.67 50.11 2929.33 2943 1 158.33 17.13 17 51.67 16.5 89 3.44
10 41.67 65.31 3092 3137.33 1.02 177.67 21.13 20.8 44.53 13 93.67 4.25
11 67.33 84.38 2812.67 2720.67 0.97 179.67 29.97 31 37.03 15.67 92 3.12
12 62.33 102.05 4609.33 4360 0.95 176.67 22.13 23.43 43.8 15 90.67 4.76
13 37 67.55 3367.67 3402.67 1.01 157.33 20.07 19.83 44.7 13.67 96.33 5.24
14 50.67 59.65 2639 2659 1.01 183.67 22.63 22.47 46.53 17 89 3.45
15 53.33 77.85 3372.67 3192.33 0.95 184 23.1 24.37 46.73 17 95.67 5.1
16 32.33 79.46 3768.33 3652 0.97 179.67 21.1 21.77 41.33 15.67 92.33 5.84
17 60 105.26 4185 4250.33 1.02 185.33 25.17 24.77 48.3 15 93.33 4.27
18 44.67 90.64 4114 4108 1 177 22 22.07 50.67 13 94.67 3.68
19 50 69.07 3289 3424.67 1.04 177.33 21.03 20.17 38.17 15 93.67 3.52
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Nasal Breathing Individual Data 
  N_RR N_VE N_VO2 N_VCO2 N_RER N_HR N_VEQO2 N_VEQCO2N_VO2_KGN_RPE N_SaO2 N_FEV1
1 29 42.66 2336.67 1741.33 0.74 149 18.27 24.53 32.37 8.33 93.33 3.39
2 22.67 48.05 2890.33 2205 0.76 139.67 16.6 21.8 36.63 9.67 96.67 3.43
3 37.33 31.85 1464.33 1210.33 0.83 146.33 21.77 26.3 25 8.67 94 3.02
4 43.67 47.79 2489 2082 0.83 141 19.17 22.93 28.43 7.33 95.67 4.27
5 20.67 39.56 2562 1884.33 0.74 110.67 15.43 21.03 30.03 8.33 95.33 5.48
6 19.33 29.16 1932.67 1420.33 0.73 134.67 15.1 20.53 25.33 8.33 98 3.95
7 16.67 24.74 1582 1113.33 0.7 116 15.67 22.3 24.57 12 92 2.79
8 28.33 18.39 722 550 0.75 126 26.5 35.17 11.6 8.33 97 2.98
9 29 30.67 1638 1301 0.8 121 18.73 23.6 28.87 10 97.33 3.28
10 20 28.5 1458.67 1168.33 0.8 123 19.5 24.4 21.03 6.67 95 4.33
11 17.67 23.08 1256.67 856 0.68 133 18.33 26.97 17.4 11 96.33 3.23
12 31 55.83 3139.67 2852 0.91 146.33 17.73 19.57 29.83 13.67 94 4.44
13 20 40.27 2293.67 2177 0.95 113 17.57 18.5 30.43 7 98.33 5.27
14 23 17.47 1340.5 885 0.66 144 13.05 19.8 23.65 16 90.5 3.59
15 22.33 40.57 2447.67 2083.67 0.85 156 16.63 19.47 33.7 11 80 5.22
16 18.33 37 2085.67 1803.33 0.86 112.67 17.7 20.53 22.87 7.67 98 5.87
17 27 41.34 2431.33 2100.67 0.86 138.33 16.9 19.67 28.07 11.33 95.33 4.23
18 25 48.05 2662.67 2467.33 0.93 129.33 18.07 19.47 32.97 8.33 96.33 3.46
19 29.33 41.16 2232.33 1953.33 0.87 125.33 18.43 21.07 25.63 7.33 95.67 3.41
N_RR2 N_VE2 N_VO22 N_VCO22 N_RER2 N_HR2 N_VEQO22N_VEQCO22N_VO2_KG2N_RPE2 N_SaO22
1 33.33 52.79 2790 2283 0.82 164 18.93 23.13 38.67 12.33 91.33
2 27.33 54.08 3194.33 2743.67 0.86 144.33 16.9 19.73 40.47 12.33 93
3 39.33 42.82 2037.33 1743.67 0.85 163.33 21.07 24.6 34.83 8.67 92.33
4 50.67 58.88 2877.67 2608.33 0.91 162 20.43 22.6 32.87 10.67 94.33
5 31.67 57.55 3292 2826.67 0.86 135 17.5 20.33 38.6 14.67 96
6 32 38.49 2532.67 1970.33 0.78 102.33 15.23 19.57 33.2 11.67 95.33
7 18 27.62 1788.67 1382 0.77 121.33 15.43 20.03 27.77 12 91
8 34.33 31.91 1691.33 1390 0.82 150.33 18.9 23.13 27.23 13.67 96
9 35.33 37.88 1986.67 1720.33 0.87 156.67 19.07 22 35.07 13.33 95
10 29 45.59 2389 2082.33 0.87 150 19.1 21.9 34.43 7 95
11 45 49.92 2315.33 1908 0.82 164 21.57 26.2 32.1 13 83.33
12 38 63.18 3600.67 3205 0.89 153 17.57 19.73 34.23 14 89
13 25.33 50.13 2916.67 2804 0.96 140.33 17.17 17.87 38.77 9.67 97.67
14 25.5 31.08 2010.5 1636.5 0.82 160.5 15.45 19 35.45 16.5 94.5
15 29 41.31 2374 2205.67 0.93 170.67 17.43 18.73 32.73 14 79.5
16 28.67 60.78 3145 3167 1.01 157.33 19.37 19.23 34.5 12.33 94.67
17 34.33 60.62 3401.33 3258 0.96 165.67 17.8 18.6 39.27 14 94.33
18 30.33 58.5 3234.67 3098.67 0.96 155.33 18.1 18.87 40.07 11.67 94.67
19 31.33 52.97 2911.33 2686.33 0.92 155 18.17 19.73 33.43 12.67 93
N_RR3 N_VE3 N_VO23 N_VCO23 N_RER3 N_HR3 N_VEQO23N_VEQCO23N_VO2_KG3N_RPE3 N_SaO23 N_FEV2
1 51 75.73 3323.67 3033.33 0.91 177 22.77 24.93 46.07 17.33 91.67 3.42
2 32 63.4 3653 3390.33 0.93 158.33 17.33 18.67 46.27 14.67 90.67 3.69
3 34.67 43.77 2322.67 2078.67 0.89 177.33 18.83 21.07 39.67 11.33 89.33 2.96
4 54 71.07 3099.33 3084.33 1 178.67 22.9 23.07 35.4 13.67 95.33 3.98
5 38 70.03 3784.33 3383.33 0.89 154.67 18.5 20.7 44.37 19 95 5.32
6 35.67 35.24 2322.67 1875.67 0.8 97.33 15.17 18.8 30.5 12.33 97.33 4.14
7 33.67 39.89 2098.33 1659 0.79 150 19.6 24.77 32.6 13 88 2.91
8 50.33 50.09 2161.33 2238.33 1.03 155.67 23.13 22.37 34.77 18.33 90.67 3.07
9 39 49.87 2388.67 2287.33 0.96 160.33 20.73 21.63 42.17 15.33 91.67 2.91
10 34.33 55.93 3062.33 2933.33 0.96 169.67 18.27 19.1 44.13 12.33 94.67 4.29
11 48 61.22 2802.33 2546 0.91 174.67 21.83 24.07 38.87 16 90 3.01
12 41 77.97 4234.33 4314.33 1.02 182.67 18.4 18.07 40.23 17 90.67 4.76
13 29.33 54.11 3310.67 3336 1.01 160.67 16.33 16.23 44 14 92 5.57
14 32 35.18 2144 1865.5 0.87 165.5 16.4 18.9 37.8 18 91.5 3.65
15 36.33 57.7 3267 3097 0.95 179.33 17.63 18.67 45.03 16 80 4.71
16 32.33 79.29 3950.67 4076.33 1.03 178 20.07 19.47 43.3 16.5 92 5.7
17 42 74.44 4022.67 4157 1.04 182.33 18.5 17.9 46.43 18 88.67 4.25
18 37 68.48 3755.67 3715.67 0.99 175.33 18.23 18.43 46.53 13.67 92 3.54
19 32 63.6 3469 3531 1.02 182 18.3 18 39.8 17 92 3.63
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